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 Pseudomonas aeruginosa is an important Gram-negative opportunistic pathogen, 
which has become a significant threat due to wide-spread antimicrobial resistance. 
Resistance Nodulation Division efflux pumps are important contributers to antimicrobial 
resistance in P. aeruginosa and other organisms. Resistance nodulation division efflux 
pumps are composed of three proteins; however, the mechanism by which the three 
proteins interact to form a functional complex remains, for the most part, unknown.  The 
goal of this project is to further our understanding of how these proteins interact, to better 
understand how these efflux pumps operate in hopes of identifying novel therapeutic 
targets. We constructed a single copy expression system to study MexJK in the presence 
of either OprM or OpmH and confirmed these constructs using qRT, immunoblot and 
MIC. Chimeric OprM proteins were constructed by swapping α-helical domains from the 
OpmH protein. Using these chimeric proteins, we were able to identify regions within 
OprM/OpmH that may be responsible for substrate specificity by generating chimeric 
proteins. Taken together this data broadens our understanding of how this complex 
interacts. 
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A. Antibiotic Resistance in Pseudomonas aeruginosa 
i. P. aeruginosa and Clinical Relevance 
 Pseudomonas aeruginosa is a Gram-negative opportunistic pathogen, prevalent in 
nosocomial infections. Pseudomonas spp. are commonly found as part of the normal flora 
on the skin but are capable of being highly infectious in immunocompromised individuals 
causing chronic pulmonary infections, particularly in cystic fibrosis (CF) patients (Gillis, 
et al., 2005) in addition to being able to cause urinary tract infections, infection of burn 
wounds and displaying high rates of infection in cancer patients (Kumari, et al., 2009). 
 The success of P. aeruginosa as a nosocomial pathogen can be attributed to its 
intrinsic resistance to several antimicrobial agents including antibiotics, biocides and 
heavy metals (Li, 1995).  As a result, P. aeruginosa infections are difficult to treat and 
often life threatening. P. aeruginosa has been identified as a primary cause of pneumonia 
in hospitals. P. aeruginosa  is the second leading cause of hospital-acquired pneumonia 
(HAP), healthcare-associated pneumonia (HCAP) and ventilator-associated pneumonia 
(VAP) with rates of infection rising in individuals that remain in the intensive care unit 
(ICU) for longer than 4 days (Driscoll, et al., 2007).  
 A study conducted in 2007 compared rates of nosocomial infections in European 
public hospitals and found that P. aeruginosa accounted for 11-13.8% of all nosocomial 
infections when a microbiological isolate was successfully identified, with a higher 
percentage of rates of P. aeruginosa infections being found in the ICU, (13.2-22.6%) 
(Driscoll, et al., 2007). Multidrug resistant (MDR) P. aeruginosa is common in Canadian 
hospitals as well. For example, a CANWARD study collected 1549 P. aeruginosa 
isolates from 15 different Canadian hospitals, of which 136 were MDR (Walkty, et al. 
2012).  It was found that the majority of MDR isolates were resistant to ceftazidime, 
piperacillin-tazobactam, meropenem and ciprofloxacin, while remaining susceptible to 
colistin (Walkty, et al. 2012).   
ii. Mechanisms of Resistance: 
 Antimicrobial resistance of Gram-negative bacteria like P. aeruginosa may be 
attributed to a combination of several mechanisms. These mechanisms include low outer 
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membrane permeability, inactivation of antibiotic by enzymes (ex. β-lactamases, 
aminoglycoside modifying enzymes), alteration of the molecular target and active efflux 
of the antimicrobial agent (Figure 1). Several clinically relevant antibiotics used to treat 
P. aeruginosa infection must traverse the cellular membrane to reach their molecular 
targets within the cell. The presence of an additional outer membrane in Gram-negative 
bacteria limits permeability of antibiotic molecules. Penetrating molecules may be 
removed from the cell by an assortment of efflux pumps. The synergistic relationship 
between the outer membrane permeability and the efflux pumps is the most important 
factor influencing intrinsic antibiotic resistance in Gram-negative bacteria like P. 
aeruginosa (Liu, et al., 1996).  
B Efflux Pumps 
i. Resistance Nodulation Division Efflux Pump Structure 
 There are five families of multidrug resistance efflux pumps: the ATP-binding 
cassette (ABC) superfamily, the major facilitator superfamily (MFS), the multidrug and 
toxic-compound extrusion (MATE) family, the small multidrug resistance (SMR) family 
and the resistance nodulation division (RND) family (Piddock, 2006). 
 Efflux of antibiotics from the periplasm is a critical mechanism of antibiotic 
resistance utilized by Gram-negative cells. P. aeruginosa is capable of actively effluxing 
antibiotics from the periplasmic space using efflux pumps primarily from the RND 
family. The RND complex is tripartite in nature, composed of an outer membrane 
channel protein (OMP), inner membrane RND transporter, and a membrane fusion 
protein (MFP) (Kumar and Schweizer, 2005). The RND transporter provides the energy 
for the molecular transport and is often referred to as the RND “pump” protein (Misra 
and Bavro, 2009). The OMP interacts with the RND protein in the periplasm producing a 
channel capable of transporting antibiotics into the extracellular space. The MFP is 
believed to stabilize the interactions between the RND transporter and the OMP (Misra 
and Bavro, 2009). All three of these components are essential for efflux function.  
The RND transporters are comprised of a homotrimer folded into an α-helical 
transmembrane domain, with a large, soluble periplasmic domain. The top of the  
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Figure 1.  Different mechanisms of antimicrobial resistance in Gram-negative 
bacteria. Bacteria have semi-permeable membranes which may limit the passage of 
some types of antibiotics into the cell. Multidrug resistance efflux pumps allow the 
bacterium to pump antimicrobials out of the cell. Porins maintain osmotic pressure by 
allowing the entrance/exit of hydrophilic small molecules but do not permit the passage 
of larger molecules. Enzymes can modify the antibiotic so that it is no longer recognized 
by the target, or modify them so that they are no longer functional. This is particularly 
prevelant with antibiotics that alter the ribosome or interfere with ribosome binding to 
inhibit protein synthesis. Inhibition of mRNA synthesis occurs by binding to DNA-
dependent RNA polymerase inhibiting initiation. Inhibition of DNA synthesis occurs by 
inhibiting either DNA gyrases or topoisomerases or binding to the alpha subunit. A 













periplasmic domain interacts with the OMP (Misra and Bavro, 2009). The crystal 
structure of AcrB, a RND transporter found in E. coli revealed that the protein contained 
three domains: the membrane-spanning domain, the pore domain and the TolC-docking 
domain (Murakami, et al., 2002). 
 The crystal structures of TolC (Koronakis, et al. 2000) and OprM (Akama, et al., 
2004) the OMPs from E. coli and P. aeruginosa respectively have been solved, and while 
there is little amino acid homology between the two proteins they fold in a similar 
homotrimeric nature both with an outer membrane-embedded β-barrel and an α-helical 
domain which extends into the periplasm (Misra and Bavro, 2009). 
 MFPs are lipoproteins which have a lipidated N-terminal end anchored to the 
inner membrane, exposing the majority of their structure to the periplasm. Crystal 
structures of AcrA (Mikolosko, et al., 2006) and MexA (Akama, et al., 2004) from E. 
coli and P. aeruginosa respectively contain three linearly-arranged domains: a β-barrel 
domain containing six anti-parallel β-strands and a shorter α-helix, and a central lipoyl 
domain made up of 4 β-strands separated by an α-helical hairpin domain (Misra and 
Bavro, 2009). It has been shown that the hairpin domain of the MFP is what is interacting 
with the OMPs, while the β-barrel is interacting with the RND transporter (Misra and 
Bavro, 2009). 
 These proteins are usually genetically encoded as part of a single operon with the 
MFP encoded first, followed by the RND transporter and finally the OMP. Often a 
regulator is found which is encoded in the opposite direction located upstream of the 
MFP. The MexAB-OprM RND efflux system in P. aeruginosa is an example of this (Li, 
et al. 1995) where mexA, mexB, and oprM are the MFP, RND transporter and OMP, 
respectively, and mexR is the repressor, encoded upstream of mexA (Srikumar, et al. 
2000). However, there are instances when the operon may consist of only the genes 
encoding for the MFP and RND proteins only, and the gene encoding for the OMP is 
encoded elsewhere in the genome. The MexJK-OpmH efflux complex in P. aeruginosa, 
would be an example of this, where mexJ and mexK are encoded in an operon, with their   
7 
 
Figure 2. Structure of a Resistance Nodulation Division efflux pump. The RND pump 
(blue), traverses the inner membrane and is a drug-proton antiporter. The membrane 
fusion protein (purple) acts as an adaptor to stabilize the interaction between the RND 
and outer membrane protein (pink). The outer membrane protein, acts as a channel, 


















































local repressor mexL, while the OMP, OpmH is found as a standalone gene elsewhere in 
the P. aeruginosa genome (Chuanchuen, et al. 2003). 
ii. Clinical Relevance of RND Efflux Pumps 
 RND pumps are widespread throughout Gram-negative organisms, and as a group 
exist as the most clinically relevant efflux system (Morita, et al. 2012). To date twelve 
RND efflux pumps have been described in P. aeruginosa, these include MexAB-OprM 
(Li, et al., 1995), MexCD-OprJ (Poole, et al., 1996), MexEF-OprN (Kohler, et al., 1997), 
MexGHI-OpmD (Aendeker, et al., 2002), MexMN (Mima, et al., 2005), MexPQ-OpmE 
(Mima  et al, 2005), MexVW-OprM (Li, et al., 2003), MexXY-OprM (Mine, et al., 
1999), TriABC-OpmH (Mima, et al., 2007), MuxABC-OpmB (Mima, et al.,2009), and 
MexJK-OprM/OpmH (Chuanchuen, et al., 2002) (Table 1). Although MexAB-OprM and 
AcrAB-TolC of P. aeruginosa and E. coli respectively, are used as models to understand 
the organization and mechanism of these RND efflux complexes, there exist many more 
examples. Specifically in P. aeruginosa, the MexXY system is known for its high levels 
of intrinsic aminoglycoside resistance, with upregulation of the complex being the most 
common form of increased resistance (Armstrong and Miller, 2010). While it is widely 
accepted that the efflux of antibiotics is not the primary function of RND pumps (Table 
1) some recent findings have shed light on their natural functions. For example, it was 
demonstrated that the expression of the MexEF-OprN pump in P. aeruginosa, when in 
the presence of a nitrosative stressor, is induced (Fetar, et al., 2011). This is particularly 
important as it is known that epithelial cells in the lungs produce nitric oxide (NO) when 
stimulated by bacteria or bacterial products. This could lead to selective pressure for 
MexEF-OprN antimicrobial resistant mutants (Fetar, et al., 2011). s- nitrosoglutathione 
(GSNO) a source of NO was shown to induce MexEF-OprN; however, when mutants 
either overexpressing or lacking these genes were tested, there was no difference in 
susceptibility to GSNO seen (Fetar, et al., 2011). This supported the hypothesis that, 
nitrosative stress may be a selective pressure for MexEF-OprN (Fetar, et al. 2011). 
MexEF-OprN is regulated by MexT, a positive regulator, which was shown to be induced 
in response to airway epithelial cells. This led to the hypothesis that MexT is related to 
pathogen-host interactions (Fargier, et al., 2012).  
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Table 1. Substrate profiles of RND multidrug efflux pumps characterized in P. 
aeruginosa. 
Efflux Pump Name Substrate Reference 
MexAB-OprM β-lactams, β-lactamase inhibitors, 
chloramphenicol, fluoroquinolones, 
macrolides, novobiocin, tetracycline, 
triclosan, trimethoprim, ethidium 
bromide, SDS, thiolactomycin, 
cerulenin, acylated homoserine 
lactones 
Poole, 2001 
MexCD-OprJ β-lactams, chloramphenicol, 
fluoroquinolones, macrolides, 
novobiocin, tetracycline, triclosan, 
trimethoprim, ethidium bromide, SDS, 
crystal violet, acriflavine 
Poole, 2001 
MexEF-OprN chloramphenicol, fluoroquinolones, 
triclosan, trimethoprim, Pseudomonas 
quinolone signal 
Kohler, et al., 2001; Poole, 
2001 
MexXY-OprM fluoroquinolones, aminoglycosides, 
tetracycline, erythromycin 
Li et al., 2002 
MexJK-OprM/OpmH erythromycin, tetracycline/triclosan Chuanchuen, et al., 2002 
MexGHI-OpmD vanadium, precursors to acylated 
homoserine lactones 
Aendekerk, et al., 2002 
MexVW-OprM chloramphenicol, fluoroquinolones, 
erythromycin, trimethoprim, ethidium 
bromide, acriflavine 
Li, et al., 2003 
MexMN chloramphenicol, thiamphenicol Mima, et al., 2005 
MexPQ-OpmE fluoroquinolones, tetracycline, 
chloramphenicol, macrolides 
Mima, et al., 2005 
TriABC-OpmH triclosan Mima, et al., 2007 
MuxABC-OpmB novobiocin, aztreonam, macrolides, 
tetracycline 






iii. Mechanism of RND Efflux Pump  
 
 Multiple studies have been performed to elucidate the domains responsible for 
pump function and specificity. In 2002, Elkins and Nikaido replaced both of the large 
periplasmic loops of AcrD a RND transporter from E. coli, with those from AcrB, also 
from E. coli, which effectively modified the substrate specificity of the AcrAD-TolC 
complex to that of AcrAB-TolC (Elkins and Nikaido, 2002). Alternatively, when they 
replaced the transmembrane regions of AcrD with those sequences of AcrB there was no 
effect on substrate specificity. This showed that the substrate specificity is determined 
primarily by the periplasmic domain and that the critical binding of substrates likely 
occurs here. 
  In 2002 Zgurskaya et al. used chimeras of the AcrB pump of E. coli and the 
MexB pump from P. aeruginosa to show that substrate specificity was largely 
determined by the second external loop of these proteins (residues 612-849) (Tikhonova, 
et al., 2002). It was also shown that the region spanning the extracytoplasmic domain 
between helices 2-7 defined the specificity of interaction with the periplasmic 
components (Tikhonova, et al., 2002). Finally they showed that the N-terminal 
periplasmic loop and the first part of the C-terminal loop are what determine the 
interaction of the RND pumps with their associated periplasmic adaptor proteins. 
 The conformational changes in RND protein structure associated with the efflux 
of substrates remains poorly defined. Several models proposing the steps required from 
substrate recognition to expulsion have been proposed (Murakami, et al. 2006; 
Fernandez-Reico, et al., 2004; Pietras, et al., 2009). Currently, the model proposed by 
Weeks et al. (Weeks, et al. 2010) is considered the strongest. This model describes a 5-
step substrate binding mechanism whereby binding of the substrate leads to opening of 
the OMP via conformational changes communicated through the MFP. These are, (i) an 
initial interaction between the AcrB hairpin loop and the TolC turns (ii) trigger a partial 
opening of TolC (iii) binding of the substrate induces conformational changes in AcrB 
which are transduced to the β-barrel and lipoyl domains (iv) direct interactions between 
the α-helical hairpin domain of AcrA and intra-protomer grooves allow for TolC helices 
to extend (v) full dilation of TolC (Weeks, et al., 2011). More recently, a 2012 study 
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performed by Lu and Zgurskaya (2012) showed that while the RND transporter is not 
directly interacting with the OMP, a lipoprotein lipase (LPL) is controlling the interaction 
between the MFP and the OMP and is linking conformational changes in the transporter 
to transport of substrate through the OMP. Therefore, it is necessary to have interaction 
of the MFP to the RND transporter in order to stimulate the activities of the transporter. 
C. Knowledge Gaps 
 Currently, very little data is available on the mechanisms of interaction between 
the three components. It is also not known what role a given substrate plays in the 
interaction of the three components, if any. 
D. Virulence and RND Pumps 
 It has been shown that in addition to antimicrobials, efflux pumps are also able to 
pump out host-derived products as well, such as virulence determinants. P. aeruginosa 
virulence relies on the ability to produce several autoinducer molecules; these molecules 
accumulate in a cell density-dependent manner and induce the expression of multiple 
targets, specifically of virulence factors. In addition, P. aeruginosa contains several 
multidrig efflux pumps which confer adaptive resistance to antibiotics. These pumps are 
also able to influence quorum sensing.  
i. Quorum Sensing 
 Acylated homoserine lactones (AHLs) are found in a large number of Gram-
negative bacteria; their accumulation in the growth medium reflects cell density and 
triggers the expression of target genes when a critical level of cell concentration is 
reached. Quorum sensing (QS) involves an autoinducer synthase, which is responsible for 
the production of autoinducer (AI) that is released into the growth medium and a 
transcriptional activator that acts together with the autoinducer to activate the target genes 
in response to the increase in cell density (Fuqua, et al. 1996). P. aeruginosa has three 
quorum sensing systems the Las, Rhl and PQS systems (Pesci, et al., 1999). Each system 
consists of genes involved in autoinducer synthesis, lasI, rhlI and pqsABCDH, as well as 
a transcriptional regulator, lasR, rhlR and pqs, respectively. These three systems are 
arranged in a hierarchal order with the Las system positively regulating both the Rhl 
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(Latifi, et al., 1996) and the PQS (Wade, et al., 2005) systems. It is possible though, for 
these systems, Rhl and PQS, to be activated in the absence of the Las system under 
certain environmental conditions, such as growth medium (Medina, et al., 2003).  The 
Rhl system has also been shown to negatively regulate the PQS system (Wade, et al., 
2005). 
 It has been reported that the P. aeruginosa RND pump MexAB-OprM is able to 
efflux out AHLs (Evans, et al., 1998) and that cells of P. aeruginosa are not permeable to 
all QS molecules (Pesci, et al., 1999). The MexAB-OprM pump is able to selectively 
efflux AHLs, including AHLs from other bacterial species (Minagawa, et al., 2012).  
Conversely it has been reported that an overexpression of these RND pumps can be 
detrimental to the cell. For example, in the MexAB-OprM system, where the AHLs are 
substrates, it has been shown to have reduced virulence for those strains overexpressing 
this pump as a result of an increase in the efflux of quorum signals (Piddock, L., 2006). 
This leads to a reduction in the expression of virulence determinants regulated by quorum 
sensing (Piddock, 2006). 
ii. Biofilm Formation 
 P. aeruginosa forms environmentally and clinically relevant biofilms and is a 
model organism for their study. P. aeruginosa is able to form a mature biofilm in 5-7 
days, following three main steps (Rosenberg, et al., 1982). The first step is attachment 
and involves the planktonic bacteria reversibly attaching to a surface (abiotic or biotic). 
After adherence to a surface, biofilms begin developing through aggregation 
characterized by an irreversible attachment to the surface, multiplication of the bacteria 
and microcolony formation. Once the biofilm is mature, individual cells or aggregates of 
cells can disperse to allow them to infect other locations (Rosenberg, et al., 1982). The 
polymeric matrix which surrounds the biofilm cells adds protection against 
environmental stresses and predation (Donlan and Costerton, 2002).  
 Several mechanisms have been shown to increase the tolerance of bacterial cells 
in a biofilm to antimicrobials. These include decreased antimicrobial diffusion, formation 
of persistor cells, and the induction of specific target genes. Specifically in P. aeruginosa, 
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the intrinsic resistance to several antibiotics has been found to increase when present in a 
biofilm (Potera, 1999) such as tetracycline, chloramphenicol, quinolones, and β-lactams. 
These patterns of resistance are similar to those substrates of the MexAB-OprM pump 
(Soto, 2013).   
 Several studies have investigated the effects of antibiotics on biofilms using 
colistin as an antimicrobial and have found that those biofilm cells in the active 
subpopulation, with a higher metabolic activity, were able to survive, whereas those in 
the inactive subpopulation located deep within the biofilm were eradicated (Pamp et al., 
2008). As well, MexCD-OprJ genes required for colistin tolerance were induced in the 
active subpopulation under colistin exposure (Chiang, et al., 2012). 
iii. Swarming Motility 
 Bacteria containing flagella may adapt their locomotion machinary when grown 
on solid surfaces for movement in order to obtain a specialized form of organized 
movement known as swarming (Calvio, et al., 2005). Swarming motility is characterized 
by the movement of bacteria in groups of tightly bound cells grown on top of solid 
media. Swarming cells are longer and more flagellated compared to non-swarm cells 
(Calvio, et al. 2005). There are several environmental signals that have been implicated 
in affecting the transition from non-swarm to swarm cells, however, cell-density signals 
seem to be most important (Calvio, et al., 2005).  
 It has been shown that swarming motility is deficient in mutant strains that 
overexpress MexEF-OprN (Kohler, et al., 2001). Swarming motility is dependent on 
rhamnolipid production, and in those strains which overexpress MexEF-OprN, 
rhamnolipid production is impaired (Kohler, et al., 2001). Rhamnolipid production is 
under the control of the Rhl system. In those strains overexpressing MexEF-OprN there is 
a decrease in rhlI transcription as well as a decrease in C4-HSL AI production, which 
may account for the decreases in rhamnolipid production (Kohler, et al., 2001). 
Rhamnolipid is a a surfactant that is required to reduce surface tension in order for the 
bacteria to spread across the surface and is controlled by quorum sensing (Kearns, 2010).  
In addition to MexEF-OprN, several efflux pumps have been shown to pump out quorum 
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sensing molecules which may reduce the amount of rhamnolipid being produced, and 
therefore the ability of swarming motility to take place. 
iv. Swimming Motility 
 P. aeruginosa may also contain a single polar flagellum which promotes 
swimming motility in liquid environments (0.3% agar) (Murray and Kazmierczak, 2006). 
In swimming motility, similar to twitching motility the cells are moving independently, 
rather than collectively through quorum sensing. It may be that RND efflux pumps do not 
affect swimming motility as they do swarming. Since swimming motility is not 
dependent on quorum sensing molecules which have been recognized as substrates for 
these pumps, the expression of these pumps likely does not affect the ability of the 
bacteria to swim. 
E. MexJK-OprM/OpmH as a Model for Antimicrobial Resistance Mechanisms 
 The MexJK pump of P. aeruginosa was first described in 2002 after a strain of P. 
aeruginosa lacking MexAB-OprM and MexCD-OprJ (PA0238-1) was exposed to 
triclosan and the resistant colonies were screened. It was found to overexpress a novel 
RND pump, MexJK, that was regulated by mexL (Chuanchuen, et al., 2002). This pump 
was found to complex with two different OMP's. MexJK-OpmH effluxes triclosan, while 
MexJK-OprM effluxes erythromycin (Chuanchuen, et al., 2002) (Figure 3). Triclosan is a 
commonly used biocide which is effluxed by most RND systems in P. aeruginosa 
(Chuanchuen, et al., 2002). Previous studies have shown that P. aeruginosa possess 
several triclosan resistance mechanisms such as the ability to generate target mutations, 
produce enzymatic modifications and through active efflux, specifically MexAB-OprM 
(Chuanchuen, et al., 2001; Chuanchuen, et al., 2003).  
 It is known that one OMP can interact with several RND-MFP complexes, TolC 
of E. coli  is known to interact with several different types of efflux pumps (Koronakis, 
2003), while OprM of P. aeruginosa interacts with  MexAB, MexJK, and MexXY 
(Poole, et al., 1993; Chuanchuen, et al. 2002; Mine, et al. 1999). The MexJK pump is 
unique since it effluxes different substrates depending on whether it forms complex with 
the OprM or OpmH protein. This asks the question of whether the two complexes, 
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MexJK-OprM and MexJK-OpmH are formed constitutively or whether their interaction 
is substrate dependent. The substrate specificity of this complex paired with the 
uncharacteristic RND-MFP complex promiscuity make MexJK-OprM/OpmH a model 
system for studying the effect substrate binding has on tripartite pump formation.  
 Since all three components of this complex are essential for pump activity, by 
determining if the pump formation is substrate dependent or constitutively expressed, we 
may be able to develop a method of controlling the formation of the complex. 
F. Hypothesis: 
 The MexJK RND efflux pump of P. aeruginosa forms functional complexes with 
outer membrane proteins OprM and OpmH, in a substrate dependent manner.  
Therefore, the objectives of this thesis were: 
 To construct a single copy gene expression system for the OprM protein in the 
MexJK overexpressing strain of P. aeruginosa. 
 To understand the molecular mechanisms of interactions of OpmH/OprM with the 




Figure 3. Organization of the MexJK-OprM/OpmH Operon. MexJK is encoded as an 
operon lacking an outer membrane component. It has been shown to form a complex with 
oprM (efflux of erythromycin), which is located as part of the MexAB-OprM operon, in 
addition to forming a complex with opmH (efflux of triclosan) which is not associated 








































A. Bacterial Strains, Growth and Culture Conditions  
 Bacterial strains used in this study are listed in Table 2. Bacteria were routinely 
cultured in Lysogeny Broth (LB) at 37 
o
C (Biobasic Inc., Markham, ON., Canada) and 
supplemented with the appropriate antibiotic where necessary to maintain plasmids at the 
following concentrations: 100 µg/mL ampicillin (Bioshop Canada Inc., Burlington, ON., 
Canada) for maintenance in E. coli and  30 µg/mL gentamicin (Bioshop Canada Inc., 
Burlington, ON., Canada), and 200 µg/mL carbenicillin (Bioshop Canada Inc., 
Burlington, ON., Canada) for that in P. aeruginosa. Counterselection for curing plasmids 
with the aid of the sacB gene was carried out in LB agar medium supplemented with 10% 
sucrose (Bioshop Canada Inc., Burlington, ON., Canada) and induction of gene 
expression was achieved by supplementing the growth medium with 1 mM isopropyl-β-
D-thiogalactopyranoside (IPTG) (Biobasic Inc., Markham, ON, Canada). 
B. DNA Manipulations 
 Plasmids and oligonucleotides used in this study are listed in Table 3 and Table 4 
respectively. Plasmid DNA was extracted using EZ-10 Spin Column Plasmid Miniprep 
Kit (Biobasic Inc., Markham, ON, Canada) according to manufacturer’s instructions. The 
DNA concentration was measured using the Eppendorf BioPhotometer Model AG 
(Barkhausenweg, Hamburg, Germany) and the samples were stored at -20 ˚C. DNA 
amplified by polymerase chain reaction (PCR) or digested with restriction enzymes, was 
resolved by 0.8% agarose (Biobasic Inc., Markham, ON, Canada) gel electrophoresis and 
purified using the EZ-10 Spin Column DNA Gel Extraction kit (Biobasic Inc., Markham, 
ON, Canada). 
i.  E. coli Competent Cell Preparation and Transformation 
 E. coli DH5α competent cells were prepared according to Inoue and colleagues 
(Inoue, et al 1990). Briefly, E. coli DH5α were subcultured with a 1/100 v/v inoculum 
from an overnight culture and grown at 37 
o
C until they reached mid log phase (OD600nm= 
0.4-0.6). Cells were harvested in a pre-chilled rotor at 3800 xg and resuspended in 0.4x of 
original volume of ice cold transformation buffer I (TFBI– 100 mM rubidium chloride 
(Fisher Scientific, Markham, ON, Canada), 50 mM manganese chloride (Bioshop Canada   
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Table 2. Bacterial strains used in this study. 
Strain Relevant Characteristics Reference/ Source 
E.coli  
DH5α F- φ80d lacZΔM15 Δ(lacZYA-argF) 
U169 deoR recA1endA1 hsdR17 (rk-
, mk+) phoA supE44 λ- thi-1 gyrA96 
relA1  
 
Taylor, et al., 1993 
MT102/pJBA132 Gfp-based-N-Acyl Homoserine-
Lactone sensor strain 
Anderson, et al. 2001 
P. aeruginosa  
PA01 P. aeruginosa prototroph  Holloway and Zhang, 
1990  
PA0238 PA01: ΔmexAB-oprM, ΔmexCD-
oprJ 




Kumar Lab Collection 
PA0200 PA01:ΔmexAB-oprM Schweizer, 1998 
PA01172 ΔmexAB-oprM, ΔmexCD-oprJ, 
ΔmexJK, ΔmexEF-oprN, ΔmexXY, 
ΔopmH, ΔtriABC 
Kumar Lab Collection 
PA050 PA0702:mini-Tn7-Lac Ganeshanantham, 2011 
PA051 PA0702:mini-Tn7-Lac-opmH-His Ganeshanantham, 2011 
PA054 PA015:mini-Tn7-Lac-oprM-His This Study 

































Table 3. Plasmids used in this study. 
Plasmid  Relevant Characteristics Reference/ Source 
pFLP2 Amp
r
, source of Flp 
recombinase, sacB allows 
for removal of plasmid by 
sucrose counterselection 




, R6K replicon, helper 
plasmid encoding site-
specific TnsABCD for Tn7 
transposition pathway  
Choi and Schweizer, 2005  
 
pJBA132 gfp-based N-Acyl 
Homoserine Lactone sensor 
plasmid 
Anderson, et al. 2001  
pPLS037 pGEMT-easy-oprM-His Kumar Lab Collection 





















































Table 4. Oligonucleotides used in this study 












73 Choi, et al 2005  
GmFRT-UP CGAATTAGCTTCAAAAGCGCTCTGA aacC1 48 Choi, et al. 2005 
GmFRT-Dn CGAATTGGGGATCTTGAAGTTCCT aacC1 49 Choi, et al. 2005 
OpmH_Fwd_RT AGTACCAGAAGGGCGACAAC  opmH 142  Ganeshanantham, 
2011 
OpmH_Rev_RT ATCGGGATGTTCAGTTCCAG  opmH 143 Ganeshanantham, 
2011 
OprM_F_RT ATCAACCTGCCGATCTTCAC oprM 144 Ganeshanantham, 
2011 






rpsL 148 Mima, et al 2009  
RpsL_Rev_RT GCTGTGCTCTTGCAGGTTGTG  rpsL 149 Mima, et al 2009  
Pae_ProC_F_RT GGCGATCCAATCCTTCCAG 
 























opmH 328 This Study 
OprM_T117F ACCACCGGCAGTCCGGCGATT oprM 340 This Study 
OprM_E481R CTCGAGTGCGGCCGCATCTTC oprM 341 This Study 
OprM_A200R GTCCAGCTGGCGCTTGAAGGC oprM 342 This Study 
OprM_R426F CGCAACATCGTCGACGTGCTC oprM 343 This Study 
OprM_T5222 TCCTTCCTTTCCCTGGCGGTA oprM 332 This Study 
MexA_A913 ACGCCACGGATGCGTGTACTG mexA 333 This Study  
*nucleotide sequence homologous to opmH gene is underlined
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Inc., Burlington, ON., Canada), 30 mM potassium acetate (Bioshop Canada Inc., 
Burlington, ON., Canada), 10 mM calcium chloride (Bioshop Canada Inc., Burlington, 
ON, Canada), 15% w/v glycerol (Bioshop Canada Inc., Burlington, ON, Canada), pH 
5.8). Cells were incubated on ice for exactly 5 minutes, harvested as above and 
resuspended in 0.04x of original volume of ice cold transformation buffer II (TFBII– 10 
mM 3-(N-morpholino) propanesulfonic acid, 10 mM rubidium chloride, 75 mM calcium 
chloride, 15% w/v glycerol, pH 6.5). Cells were incubated on ice for 30-60 mins and 100 
µl aliquots were made and immediately frozen on dry ice to be stored long term at -80 
°C. 
 Transformations of chimeras were performed using the heat shock method 
(Sambrook and Russell, 2001). Briefly, 100-500 ng of DNA was added to 100 µl 
competent cells and incubated on ice for 10 minutes, heat shocked at 42 °C for 45 
seconds and incubated on ice for another 2 minutes. The reaction was added to 895 µL 
LB media and transformation reactions were recovered at 37 °C for 1 hr with shaking and 
plated on LB agar media containing the appropriate antibiotic for selection. 
ii.  P. aeruginosa Electroporation 
 All plasmids were delivered into P. aeruginosa using the rapid electroporation 
method as described previously by Choi et al., 2006. Briefly, 4x 3 mL P. aeruginosa 
overnight cultures of recipient cells were spun down at 16000 x g and washed twice with 
1 mL of room temperature 300 mM sucrose and concentrated to a final volume of 200 µl. 
Cells (100 µL) were transferred to an electroporation cuvette (0.1 cm gap) (Fisher 
Scientific, Markham, ON, Canada), and 300 ng of plasmid DNA was added. Cells were 
shocked with a 2500 V electrical pulse for 5 milli-seconds using the Electroporation 2510 
(Eppendorf, Westbury, NY, USA) electroporator, diluted immediately in 1 mL of room 
temperature LB and allowed to recover for 1 hour at 37 °C with shaking before plating on 
LB agar containing appropriate antibiotic for selection. 
iii. Mini-Tn7 Based Single-Copy Gene Delivery System 
 Recipient P. aeruginosa overnight culture was concentrated from 12 to 2 ml and 
electroporated as described above with ~300 ng each of the mini-Tn7 and the 
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transposase-encoding pTNS2 plasmids. Selection of cells containing successful 
integration was performed on medium containing 30 μg/mL gentamicin, and verified 
with Tn7R_Fwd and Pa_glmS_Rev primers that bind to the vector backbone and P. 
aeruginosa glmS gene (present immediately upstream of the insertion site) respectively, 
which generated a 292 bp PCR product. Once insertion was verified, the gentamicin 
resistance marker aacC1 was removed by the Flp-FRT system as described previously 
(Hoang, et al. 1998). Briefly, overnight cultures of P. aeruginosa containing the marked 
insertions were electroporated with 50 ng-100 ng of Flp-recombinase-encoding pFLP2 
and transformants were selected for on LB-agar supplemented with 200 μg/mL 
carbenicillin and screened for sensitivity to gentamicin by patching on LB agar 
supplemented with 30 µg/mL gentamicin and 200 μg/mL carbenicillin, respectively. 




phenotype.  This was 
achieved by streaking cells on 10% sucrose plates and incubating overnight at 37 
o
C. 
Curing of the plasmid was confirmed by patching isolated colonies on LB agar 
supplemented with 200 μg/mL carbenicillin, 30 µg/mL gentamicin, and 10% sucrose, 






 patches was 
confirmed once again by using PCR for mini-Tn7 insertion as well as for the aacC1 gene. 
C. Quantitative-Reverse Transcriptase Polymerase Chain Reaction (qRT-PCR) 
i. RNA Extraction 
 Total RNA was extracted from cells using the RNeasy RNA isolation kit (Qiagen, 
Mississauga, ON, Canada). Briefly, cells were grown by subculturing an overnight 
culture 1:100 (v/v) into fresh LB broth. When required, cultures were induced at A600nm
~
 
0.6 through the addition of 1.0 mM IPTG. At A600nm ~0.8, 1.5 mL of cells were harvested 
by centrifugation at 17 000 x g at room temperature for 3 minutes. Cell pellets were 
frozen on dry ice and placed at -80 °C for 30 minutes to facilitate cell lysis. Cells were 
then thawed at room temperature and resuspended in a buffer (proprietary) containing 
400 μg/mL lysozyme (Bioshop Canada Inc., Burlington, ON, Canada) and then transfered 
to a buffer containing guanidine-isothiocyanite (proprietary), which inactivates RNases. 
Total RNA was precipitated with 95-100% ethanol and the solution was applied to an 
RNeasy silica membrane. The membrane was washed with an ethanol containing wash 
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buffer (proprietary). RNA was eluted off of the column using RNase-free water. Quality 
and concentration of the sample were determined by spectrophotometry. RNA samples 
with concentrations no less than 400 ng/μl were used for further analysis. 
ii. Complementary-DNA Synthesis 
 Contaminating genomic DNA was removed using the RNase-free DNase kit 
(Qiagen, Mississauga, ON, Canada) according to the manufacturer’s instruction. Briefly, 
1 µg of total RNA was incubated with 1.0 unit of DNase for 40 minutes at 37 °C, DNase 
was heat inactivated at 70 °C for 5 minutes and 800 ng of RNA was reverse transcribed 
with the iScript Reverse Transcriptase (BioRad Laboratories, Hercules, CA, USA) 
according to the manufacturer's instructions. No reverse transcriptase (NRT) controls 
were included with every cDNA preparation to rule out genomic DNA contamination. 
iii.  Real-Time PCR 
 Real-Time PCR was performed in the CFX-96 Thermal Cycler (BioRad 
Laboratories, Hercules, CA, USA) using Evagreen Sso-fast PCR supermix (BioRad 
Laboratories, Hercules, CA, USA). Cycling conditions were as follows: 95 °C 3 minutes; 
(95 °C 10 seconds; 60 °C 30 seconds) for 39 cycles. High-resolution melt conditions used 
were: 95 °C 10 seconds, 65 °C – 95 °C in 0.5 °C increments, 5 seconds/ °C. Primers used 
for detection of oprM (110 bp product), mexK (122 bp product), reference gene rpsL (242 
bp product) and reference gene proC (106 bp product) were designed previously 
(Ganeshanantham, 2011). Efficiency of each primer set was determined by creating a 
standard curve using 10-fold dilutions of pooled cDNA samples. Primer sets with 
efficiencies below 95% or above 105% were omitted. No Reverse Transcriptase (NRT) 
controls for the housekeeping genes were included to rule out contamination by genomic 
DNA. A No Template Control (NTC) for each gene was also included. Expression of 
target genes under induced and uninduced conditions was assessed and normalized to a 
reference gene using the CFX Manager Software, Gene Expression Analysis tool 
(BioRad Laboratories, Hercules, CA, USA). The quality of the mRNA was assessed by 
ensuring the Ct-value remained constant for the housekeeping gene between runs. For 
gene expression analysis the ΔΔCt method was employed (Livak and Schmittgen, 2001).  
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D Protein Purification and Immunodetection 
i.  Sodium Dodecyl Sulphate-Polyacrylamide Gel Electrophoresis (SDS-PAGE) 
 SDS- PAGE was performed according to Laemmli (Laemmli, 1970), with some 
modifications. Briefly, 10 ng of protein (in a volume of 6 µL) was added to 2X SDS 
Sample Buffer (0.2% w/v bromophenol blue, 20% v/v glycerol, 0.6% v/v β-
mercaptoethanol, 4% w/v SDS dissolved in a 62.5 mM Tris buffer pH 6.8) and incubated 
at 100 °C for 5 minutes, and centrifuged at 16 000 xg for 1 minute. The samples were 
electrophoresised using a  6% polyacrylamide stacking gel with a 12% polyacrylamide 
resolving gel. The stacking gel was composed of 2.18 mL mQH2O, 0.38 mL 40% bis-
acrylamide (6% final concentration), 0.38 mL 1.0 M Tris pH 6.8 (125 µM final 
concentration), 30 µl 10% SDS (0.1% final concentration), 30 µl 10% ammonium 
persulfate (0.1% final concentration) and 4 µl TEMED (0.1% final concentration). The 
resolving gel was prepared by combining 3.2 mL mQH2O (milliQ water),  2.3 mL 40% 
bis-polyacrylamide (12% final concentration) (Bioshop, Canada Inc, Burlington, ON, 
Canada), 1.9 mL 1.5 M Tris pH 8.8 (0.38 M final concentration) (Bioshop, Canada Inc, 
Burlington, ON, Canada), 75 µl 10% SDS (0.1% final concentration) (Bioshop, Canada 
Inc, Burlington, ON, Canada), 75 µl 10% ammonium persulfate (0.1% final 
concentration) (Bioshop, Canada Inc, Burlington, ON, Canada) and 6 µl 
tetramethylethylenediamine (TEMED) (0.1% final concentration) (Bioshop, Canada Inc, 
Burlington, ON, Canada). 3 µl of pre-stained molecular weight standard (Bio-Rad, 
Mississauga, ON, Canada) was used. Gels were electrophoresised at 80 V for 30 mins 
followed by 120 V for 2.5 hrs in 25 mM Tris, 192 mM glycine, 0.1% SDS pH 8.3. Gels 
were then stained with either Coomassie Brilliant Blue (CBB) or silver stain as described 
below. 
ii.  Preparation of Whole Cell Lysate 
 Overnight cultures were subcultured 1:100 v/v, into a 4 mL volume of LB, and 
when required, induced by addition of 1.0 mM IPTG at an A600nm of 0.4-0.5, and 
harvested at A600nm 0.8-1.0. Cells were harvested by centrifugation at 17 000 xg for 3 min 
at room temperature and resuspended in 2X SDS Sample Buffer (SB) (Laemmli, 1970). 
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Cell number in each sample was standardized by adding 2X SB according to the  
formula: mL of 2x SB = 0.08x A600nm of culture. Samples were boiled for 5 minutes, spun 
down, and 4 μl of each sample was resolved on a 10% SDS-PAGE.  
iii. Extraction of Membrane Proteins 
 Membrane proteins were extracted as described by Cuenca and colleagues 
(Cuenca, et al., 2003) with some adaptations. Briefly, cell pellets from 1 L P. aeruginosa 
cultures were harvested by centrifugation at 7440 x g for 10 mins at 4 °C and frozen at -
20 
o
C overnight to facilitate lysis. Pellets were thawed for 30 minutes at room 
temperature and washed twice with 20% original culture volume (200 mL) phosphate 
buffer (800 mM K2HPO4, 20 mM KH2PO4, pH 7.2). Samples were spun at 4740 x g for 
15 minutes at 4 °C. Pellets were resuspended in 20% v/v phosphate buffer and lysed 
using the French press (Thermo Scientific, Markham, ON, Canada) at 2000 psi on ice. 
Cell debris was removed by centrifugation, at 7440 x g for 10 min at 4 °C (repeated 
once). Membrane fractions were collected by centrifugation at 105 000 x g for 1 hr at 4 
°C using the Sorvall® Discovery 100SE ultracentrifuge (Mandel Scientific, Guelph, ON, 
Canada). Pellets were solubilized in phosphate buffer containing 2% sodium lauryl 
sarcosinate and stored at -20 °C until use. 
iv. Coomassie Brilliant Blue Staining 
 Gels were stained according to Meyer and Lambert (Meyer and Lambert, 1965). 
Briefly, the gels were placed in 0.05% CBB (MP Biomedicals LLC, Solon, OH, USA) 
dissolved in 50% methanol, 10% acetic acid, and incubated overnight, at room 
temperature, with shaking.  Gels were destained for 1.5 hours in destaining solution (40% 
methanol, 50% water, 10% glacial acetic acid) prior to being photographed. 
v. Immunodetection of Proteins 
 SDS-PAGE was performed as described above. Proteins were transfered (100 V 
for 2 hours) onto a nitrocellulose membrane (Thermo Scientific, Mississauga, ON, 
Canada) in pre-chilled transfer buffer (119 mM Tris, 4 M Glycine, 0.1% w/v SDS, 20% 
v/v methanol) containing an ice pack at room temperature. Membranes were recovered 
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and blocked overnight at 4 °C with shaking at 60 rpm, with either Phosphate Buffered 
Saline pH 7.2 containing 0.1% Tween 20 (PBST) and 10% skim milk (OprM) or PBST 
and 3% Bovine Serum Albumin (BSA) (MexK, OpmH) (Fisher Scientific, Markham, 
ON, Canada). Membranes were washed three times in 50 mL PBST for 5 mins. 
Membranes were then incubated in 1% w/v BSA, 20mL PBST and goat α-opmH 
(Chuanchuen, et al., 2005) (1:10000 v/v), or rabbit α-OprM (1:10000 v/v) (a gift from Dr. 
Herbert Schweizer, Colorado State University, Fort Collins, CO, USA), or goat α-MexK 
(a gift from Dr. Herbert Schweizer, Colorado State University, Fort Collins, CO, USA) 
(1:20000 v/v) or rabbit α-His (Fisher Scientific, Markham, ON, Canada) (1:10000 v/v). 
Membranes were washed three times in 50 mL PBST for 5 mins. Membranes were 
incubated with secondary antibody for 1 hour with shaking at 60 rpm as follows: a 
1:20000 v/v dilution of either 2 mg/mL horseradish peroxidase (HRP)-conjugated goat α-
rabbit (Bioshop Canada Inc. Burlington, ON, Canada) or HRP- conjugated mouse α-goat 
(Thermo Scientific, Rockford, IL, USA) diluted in PBST + 3% w/v BSA. OpmH and 
MexK required α-rabbit while OprM required α-goat secondary antibodies. Membranes 
were washed three times in 50 mL PBST for 5 mins, and again for 5 min with PBS. Blots 
were developed by addition of 1:10 v/v diluted Pierce ECL detection reagent (Pierce 
Biotechnology, Rockford, IL, USA).  X-ray film (CL-Xposure Film, Pierce 
Biotechnology, Rockford, IL, USA) was exposed to the blot for 30 secs up to 5 mins. 
vi. Antibody Partial Purification using Ammonium Sulfate Precipitation 
 Ammonium sulfate precipitation was performed to remove debris from goat α-
MexK IgG according to Harlow and Lane (Harlow and Lane, 1988). Briefly, 5 mL of 
antibody was centrifuged at 3000 xg for 30 min at 4 °C; supernatant was collected, 
stirred, and 0.5 X total volume of saturated ammonium sulfate was added drop-by-drop 
until a precipitate started to form. The solution was stored at 4 °C overnight to ensure a 
homogenous precipitation. The sample was centrifuged at 3000 xg for 30 min at 4 °C and 
the supernatant was collected in a clean beaker and stirred at room temperature. 0.5 X 
saturated ammonium sulfate was added drop-by-drop until a precipitate formed, and the 
solution was stored at 4 °C for approximately 6 hours. The precipitate was collected by 
centrifugation at 3000 xg for 30 min at 4 °C and the supernatant discarded. The pellet 
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was resuspended in 1X total of the original volume PBS and dialyzed using 12-14 kDa 
molecular weight cut off dialysis tubing at 4 °C overnight. Sample was removed from 
dialysis tubing and centrifuged at 3000 xg for 30 min at 4 °C. The supernatant was 
divided in 1 mL aliquots and kept at -20 °C until use. 
E Domain Swapping Experiment 
 Previous studies using MexAB-OprM as a model had identified amino acids 
within OprM that when modified, changed the resistance profile and/or modified OprM 
production (Nehme and Poole, 2007). When an amino acid substitution was made in the 
form of T209A, both OprM production and resistance were changed (Nehme and Poole, 
2007). However, when an amino acid substitution was made in the form of G216A or 
G424A only the resistance pattern was changed (Nehme and Poole, 2007). For these 
reasons, a range of amino acids from 192-204, 418-433 and 192-433 in OprM were 
replaced with corresponding domains from OpmH (192-206, 425-440, 192-440). A PCR-
based mutagenesis protocol adapted from Elkins and Nikaido was used to construct the 
chimeras harbouring the swapped domain of OprM protein with those of OpmH (Figure 
4) (Elkins and Nikaido, 2002). Briefly, primers were designed to amplify the nucleotide 
sequences encoding the target domain of OpmH. These primers contained 5’-overhangs 
with homology to the nucleotide sequence in oprM flanking the domain to be replaced. 
Gene construction software was used to ensure that the swapping of domains did not 
affect the reading frame of the oprM gene. Nucleotides encoding a domain in opmH were 
amplified using long primers that also contained sequences for the template oprM. The 3’ 
ends of the primers were designed to bind to specific domains of oprM, whereas the 5’ 
ends of the primers were designed to bind to the corresponding domains of opmH. The 
PCR product from first step was used as the primer in a second PCR reaction with the 
QuikChange Lightning Site-Directed Mutagenesis Kit (Agilent Technologies, 
Mississauga, ON, Canada). A plasmid containing the wild-type allele of oprM was used 
as a template ensuring that the entire plasmid was amplified with a precise replacement of 
the desired domain from OpmH (Figure 4). Cycle conditions were described by the 
manufacturer (denaturation at 95 °C for 2 mins, then 18 cycles of 95 °C for 20 sec, 
annealing at 60 °C for 10 secs, elongation at 68 °C for 30 sec/kb of plasmid length, 
33 
 
followed by a final extension at 68 °C for 5 mins). Following PCR reaction, the entire 
reaction mixture was treated with DpnI in order to remove the template plasmid, and 10 
μl was transformed into E. coli DH5α competent cells to be screened by PCR for the 
replacement of domains. 
F Antibiotic Susceptibility Testing 
 Antibiotic susceptibility assays were performed by three different methods as 
described below:  
i.  Agar Dilution Method 
 Overnight cultures were subcultured 1:100 v/v in a 3 mL volume of LB, grown to 
an A600nm~0.5-0.6, standardized using a 0.5 McFarland standard in a 0.85% sodium 
chloride solution according to Clinical Laboratory Standards Institute (CLSI) guidelines 
(Clinical and Laboratory Standards Institute, 2011). Cells were then diluted 1:50 v/v in 
Mueller-Hinton Broth (MHB) and a 2 μl volume was spotted onto Mueller-Hinton Agar 
(MHA) plates in triplicate. Agar plates were made by adding antibiotic (erythromycin) 
(Biobasic Inc., Markham, ON, Canada), or antimicrobial (triclosan) (Biobasic Inc., 
Markham, ON, Canada) to a final concentration ranging from 1 μg/mL - 256 μg/mL in 2-
fold serial increments.  Stock solutions of erythromycin were prepared in ethanol while 
those of triclosan were prepared in methanol. MHA medium was supplemented with 1.0 
mM IPTG to induce the expression of desired proteins. Plates were incubated at 37 °C for 
18 hours. The MIC was determined to be the lowest concentration of antimicrobial that 
inhibited the growth of cells. 
ii.  Broth Dilution Method 
 Overnight cultures were standardized according to the Agar Dilution Method 
described above. Cells were added to the wells, induction of oprM expression was 




Figure 4. Schematic of protocol for swapping of OpmH domain into OprM. In 
reaction 1, amplification of opmH was accomplished using a pair of hybrid primers which 
produce opmH with small primer overhangs which are complimentary to oprM. This 
occurs because the primers contain complementary extensions (approximately 25 nt) to 
the intended start or end sites of oprM. In reaction 2, this product from reaction 1 was 
used to prime the second PCR reaction, thereby amplifying the entire pUC18T-mini-Tn7-
oprMHis plasmid containing the opmH/oprM chimera. The product from the second 
reaction was treated with DpnI to digest the methylated parental DNA. After digestion, 






















ranging from 1 μg/mL - 1024 μg/mL in 2-fold serial increments were prepared in 96-well 
plates (Sarstedt Canada, Montreal, QC, Canada) in triplicate for each condition tested 
ranging from 1 μg/mL - 1024 μg/mL in 2-fold serial increments were prepared in 96-well 
plates (Sarstedt Canada, Montreal, QC, Canada) in triplicate for each condition tested. 
Plates were incubated at 37 °C for 18 hours and MIC was determined to be the lowest 
concentration of antibiotic which was found to inhibit bacterial growth. 
 
iii.  Disc Diffusion Method 
 Overnight cultures were standardized in the same manner as for Agar Dilution  
Method described above. A sterile cotton swab was used to spread cells on an MHA plate 
for each condition tested (i.e. +/- 1.0 mM IPTG). Two discs of 15 μg/mL erythromycin 
were added to the plate at opposite ends. Plates were incubated at 37 °C for 18 hours and 
the zone of inhibition was measured around each of the discs and recorded. 
 
G Virulence Assays 
i. Biofilm Assay 
 Biofilm assays were performed according to O’Toole and Kolter (O’Toole and 
Kolter, 1998) with some modifications. Briefly, overnight cultures were subcultured 1:25 
v/v in a 3 mL volume of MHB, grown to an A600nm~0.5-0.6, and standardized in the same 
manner as for MICs described above. Cells were then diluted 1:100 v/v in MHB and a 
100 µl volume was added in triplicate to a flat bottom 96-well plate. Plates were 
incubated at 37 °C for 24 hours without shaking. Medium was removed by inverting the 
plate and shaking gently, the plate was washed three times with distilled water. Crystal 
violet, 125 µl (0.5% [w/v]), was added to the wells and incubated at room temperature for 
20 minutes. Crystal violet was washed out with distilled water three times and replaced 
with 150 µl of 95% ethanol. The ethanol incubated at room temperature for 20 minutes 
and was then transferred to a new plate. Absorbance was measured at A550nm. 
ii. N-Acyl Homoserine Lactone (AHL) Assay 
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 AHL bioassays were performed using the method described by Anderson et al. 
2001 with some modifications. Briefly, overnight cultures of E. coli MT102 harbouring 
pJBA132 and P. aeruginosa strain to be tested were standardized using a 0.5 McFarland 
standard in a 0.85% w/v sodium chloride solution according to CLSI guidelines (Clinical 
and Laboratory Standards Institute, 2011). Five microliters of the standardized solution 
was streaked close to each other in the shape of a `T` on an LB plate ensuring that the 
cultures did not touch each other. Plates were incubated at 30 °C, and examined for green 
fluorescence after 48 hours on the Dark Reader Transilluminator (Clare Chemical, 
Dolores, CO, USA). 
iii. Swimming and Swarming Assays 
 Swimming and swarming assays were carried out according to Rashid and 
Kornberg (Rashid and Kornberg, 2000). Briefly, overnight cultures were subcultured 
1:100 v/v in a 3 mL volume of LB broth, grown to an A600nm of 0.4-0.6 and standardized 
as above using a 0.5 McFarland standard. Standardized cells were spotted on LB agar 
plates containing 0.3% w/v agar (for swimming assay) and 0.5% w/v agar (for swarming 
assay). Plates were incubated for 48 hours and checked and photographed using a Canon 
Powershot SD750 every 24 hours. 
H DNA Sequencing and Analysis 
 DNA sequencing was carried out at the Genome Quebec facility at McGill  
University, Montreal, QC. The sequence analysis was performed using Basic Local  
Alignment Search Tool (BLAST) and Gene Construction Kit Software (Textco 
Biosoftware). 
 
I Modelling of Hypothetical Homology Models 
 Protein structure predictions were performed with Protein Homology/analog Y 
Recognition Engine v2.0 (Phyre2) (Kelley and Sternberg, 2009) available on the web 
(http://www.sbg.bio.ic.ac.uk/Phyre2/). Full amino acid sequences of (OpmH, 483 amino 
acid residues), (OprMopmHH1, 461 amino acid residues), (OprMopmHH3, 466 amino acid 
residues), (OprMopmHH1:3, 464 amino acid residues), and (OprMopmHH1-3, 474 amino acid 
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residues) were applied to PHYRE 2. All models were generated using the template of the 
crystal structure of OprM (at a 2.56 Å) (template 1wp1) with 100% confidence.  
J Statistical Analyses 
 Data represents the mean ± standard deviation of at least two independent 
experiments unless otherwise stated. Statistical significance was determined using the 
student's t test or ANOVA as appropriate. p < 0.05 was considered statistically 



































A. Single-copy expression of OprM 
 Expression of OprM in single-copy was achieved by the use of a mini-Tn7-based 
system. Insertion of the vector backbone and removal of the Gm-resistance cassette gene 
was confirmed by PCR (Figure 5a and 5b). Expression of OprM was confirmed by qRT-
PCR (Figure 6b), SDS-PAGE and immunoblotting (Fig 7a and 7b) as described in later 
sections. 
i. Quantitative Real-Time (qRT-PCR) Analysis of mRNA Expression 
 Expression of MexK was approximately 15-fold higher compared to wild-type in 
single-copy constructs, PA051 and PA058 (Figure 6a). PA051 and PA058 overexpress 
MexK, whereas PA01 does not express the MexJK pump, therefore a 15-fold increase in 
expression was expected.   
 qRT-PCR analysis of OprM demonstrated an approximately 30-fold 
overexpression of oprM-H6 mRNA in PA058 strains that were induced compared to 
uninduced cells (Figure 6b) which correlated to an increase in protein concentration 
(Figure 7b). This demonstrates that the OprM expression mutant was functional, and 
capable of increasing mRNA levels under inducing conditions.  
 These results taken together, demonstrate an ideal system to examine OprM 
within the MexJK-OprM complex because PA058 constitutively overexpresses the 
MexJK proteins, and OprM expression can be controlled through induction.    
ii. Protein Expression Analysis 
 In order to verify the qRT-PCR data, and to demonstrate that increases in 
transcription led to increases in translated protein, SDS-PAGE and immunoblotting were 
performed after membrane protein preparation on the two outer membrane proteins 
OprM, and OpmH along with the RND transporter, MexK. Upon induction of OprM 
from P. aeruginosa single-copy construct PA058 and a membrane protein preparation, a 
faint band of approximately 50 kDa, which is the expected molecular weight of OprM 
could be visualized by SDS-PAGE with CBB (Figure 7a). In order to confirm these  
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Figure 5. Verification of P. aeruginosa PA058 by PCR. (a) Removal of Gm 
resistance cassette. 1. 100 bp ladder; 2. PA058 (Isolate 1); 3. PA058 (Isolate 2); 4. 
PA052; 5. PA054 6. No Template Control (NTC) (b) Confirmation of the presence of 
mini-Tn7 vector after removal of Gm cassette. 1. 100 bp ladder; 2. PA058 (Isolate 1); 
3. PA058 (Isolate 2); 4. PA054; 5. PA015; 6. NTC. PCR was carried out using primers 
GmFRT-UP and GmFRT-Dn in addition to  Tn7R_Fwd and Pa_glmS_Rev (listed in 
Table 3) for confirmation of removal of Gm cassette, yielding a 548 bp product and for 





























Figure 6. Quantitative-Real Time Polymerase Chain Reaction Analysis of mRNA 
Expression.  Total RNA was extracted from induced and uninduced mid-log phase P. 
aeruginosa strains. (a) MexK. Normalized expression (using proC as housekeeping gene) 
analysis shows ~15-fold overexpression of MexK in PAO51 (OpmH
+
) and PAO58 
(OprM
+
) when compared to the wild-type PAO1. (b) OprM (in PA058). Normalized 
expression (using rpsL as housekeeping gene) analysis shows a ~30-fold overexpression 
under inducing conditions (1.0 mM IPTG) compared to uninduced cells. Data shown is 




































findings, further probing with rabbit α-OprM IgG antibody confirmed the presence of 
OprM (Figure 7b). 
 Upon induction of OpmH from P. aeruginosa single-copy construct PA051 and 
membrane protein preparation, a faint band of the expected molecular weight (also 50 
kDa) could be visualized for OpmH. A more prominent band was observed after 
induction from a multi-copy system when subjected to SDS-PAGE and CBB (Figure 8a). 
In order to confirm the presence of OpmH, immunoblotting with Goat α-OpmH IgG 
antibody was performed. Although some non-specific protein binding was observed, a 
faint band of the expected 50 kDa molecular weight was produced by PA051, and a more 
prominent band of the same molecular weight was produced from the multi-copy system 
(Figure 8b). Taken together this suggests the 50 kDa protein band was indeed OpmH. 
 Both P. aeruginosa constructs PA051 and PA058 constitutively overexpress 
MexK from a single-copy plasmid under the control of the mexL repressor. MexK 
expression and membrane protein preparation resulted in a faint band at the expected 
molecular weight of 117 kDa after SDS-PAGE and CBB (Figure 9a). Although some 
difficulties were encountered, including non-specific binding, and apparent low affinity 
for MexK when probed with Goat α-MexK IgG antibody a very faint band could be 
observed at the approximate molecular weight of 120 kDa (Figure 9b) after antibody 
clean up protocols were performed.   
iii. Antibiotic Susceptibility Profile 
 The phenotypic verification of the constructs was analyzed through antibiotic 
susceptibility assays where the MIC for each strain was determined by either broth 
dilution (erythromycin) or agar dilution (triclosan) according to the CLSI guidelines. The 
MexJK-OprM complex has been shown to efflux erythromycin (Chuanchuen, et al., 
2001); therefore resistance to this antibiotic was used as an indicator of a functional 
complex being formed. In contrast, the MexJK-OpmH complex specifically effluxes 
triclosan (Chuanchuen, et al., 2001), therefore, resistance to triclosan was used as an 
indicator of a functional MexJK-OpmH complex being formed.  
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Figure 7. Protein Expression Analysis from Membrane Protein Preparation 
Demonstrating Protein Expression of OprM. Membrane protein analysis from P. 
aeruginosa PA0702 cells containing mini-Tn7-oprM (PA058) or mini-Tn7-opmH 
(PA051) were grown to A600nm of 0.6, induced (1.0 mM IPTG) and harvested at A600nm of 
1.0 as described in the Materials and Methods.(a) SDS-PAGE.  Membrane proteins were 
isolated as described in the Materials and Methods and subjected to denaturing 12% 
SDS-PAGE and stained with CBB. Membrane protein from PA051 -/+ 1.0 mM IPTG 
was included as a negative control and membrane protein from PA01 (Wild type 
expression of OprM) was included as a positive control. Arrow indicates the expected 
migration position for OprM. (b) Immunoblot. Immunoblot was probed with a 1:10000 
dilution of polyclonal rabbit α-OprM antibody, and subsequently probed with a 1:20000 























Figure 8. Protein Expression Analysis from Membrane Protein Preparation 
Demonstrating Protein Expression of OpmH. Membrane protein analysis from P. 
aeruginosa PA0702 cells containing mini-Tn7-oprM (PA058) or mini-Tn7-opmH 
(PA051) were grown to A600nm of 0.6, induced (1.0 mM IPTG) and harvested at A600nm of 
1.0 as described in the Materials and Methods.(a) SDS-PAGE. Membrane proteins were 
isolated as described in the Materials and Methods and subjected to denaturing 12% 
SDS-PAGE and stained with CBB. Membrane proteins from PA058 -/+ 1.0 mM IPTG 
were included as a negative control and whole cell lysate from pET1.6-opmH (multi-copy 
overexpression of OpmH) was included as a positive control. Arrow indicates the 
expected migration position for OpmH. (b) Immunoblot. Immunoblot were probed with 
a 1:10000 dilution of polyclonal Goat α-OpmH antibody, and subsequently probed with a 


















 P. aeruginosa PA058 (expressing OprM) displayed resistance upon induction of 
OprM to erythromycin (Table 5) with a 4-fold change in MIC when compared to 
uninduced cells, which behaved similar to the control strain, PA050, which lacks both 
OprM and OpmH but expresses the MexJK proteins. This resistance was not observed in 
P. aeruginosa strain PA051 (expressing OpmH), indicating that the increase in resistance 
to erythromycin is due to the expression of the oprM gene specifically. 
 Conversely, P. aeruginosa PA051 cells displayed increased resistance to triclosan 
upon induction (Table 5) with an 8-fold change in MIC when compared to uniduced cells 
which behaved similiar to the control strain PA050. This enhanced resistance to triclosan 
was not observed in P. aeruginosa strain PA058 (expressing OprM), indicating that the 
increase in resistance to triclosan is due to the expression of the opmH gene specifically.  
 Taken together, this data shows that the MexJK pump forms functional complexes 
with OprM and OpmH proteins which is critical to the analysis of pump function in vivo.  
B. Virulence Assays 
 RND efflux systems are notorious for having broad substrate specificities, and 
although antimicrobial efflux is the most prominent reason for studying RND efflux 
systems, some evidence has begun to accumulate which suggests that efflux pumps have 
important roles in a virulence capacity during infection, perhaps by effluxing various 
virulence factors. Indeed, other RND efflux systems such as the MexGHI-OpmD 
complex from P. aeruginosa have been shown to be critical for growth, antibiotic 
susceptibility and virulence by promoting cell-to-cell communications (Aendekerk, et al., 
2005). In order to assess the role MexJK-OpmH/OprM plays in virulence, a variety of 
assays were performed using various RND efflux mutants. 
i. Biofilm Formation 
 All strains tested appeared to be capable of producing biofilm. PA050, which is 
deficient in an outer membrane protein for MexJK was capable of biofilm production, 
demonstrating that an intact RND pump with its outer membrane protein is not absolutely 
required for biofilm production. The MexJK-OpmH strain, PA051, showed a significant 
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1.7-fold (p=0.009) increase in biofilm production compared to PA050 in the absence of 
IPTG or a significant 1.4-fold (p=0.0009) increase in the presence of IPTG compared to 
PA050 (Figure 10a), suggesting that the OpmH protein may play a role in biofilm 
production, we hypothesize through cell-to-cell signalling. The MexJK-OprM strain, 
PA058, produced an even more dramatic 2.6-fold (p=0.008) increase in biofilm 
production compared to PA050 in the absence of IPTG, and a significant 2.2-fold 
(p<0.0001) increase in the presence of IPTG (Figure 10a). Additionally, PA058 showed a 
significant 1.6-fold (p=0.05) increase in biofilm compared to PA051 in the absence of 
IPTG, and a significant 1.5-fold (p=0.0004) increase in the presence of IPTG (Figure 
10a). This demonstrates that the MexJK-OprM strain PA058 produced the most biofilm 
regardless of induction, and that the MexJK only strain PA050 produced the least amount 
of biofilm. However, there were no significant differences between uninduced or induced 
growth conditions amongst the 3 strains, underlying reasons for which were not 
investigated in this work.     
 Given that it is suspected that the interaction of MexJK pump with OprM or 
OpmH is substrate-driven, we decided to further test each strain's ability to form biofilm 
in the presence of erythromycin.  Erythromycin is a common antibiotic used to treat 
Gram-positive lung infection. Many Gram-positive lung infections tend to be 
polymicrobial, meaning that they often contain Gram-negative bacteria as well, we 
wanted to test the effect that treating these infections would have on P. aeruginosa  
biofilm formation as P. aeruginosa is not only commonly found in the lung, but also 
readily forms biofilm in the lung. Curiously, all strains tested showed the general trend of 
increasing biofilm production as the concentration of erythromycin increased (Figure 
10b-d), although the concentrations of erythromycin used here were no less than 1/8 the 
MIC depending on the strain, and were increased up to the MIC concentration in some 
strains. 
 The MexJK strain which lacks an outer membrane protein, PA050, generated 
significantly more biofilm in the presence of erythromycin at all concentrations 
independent of induction (Figure 10b). Unexpectedly, there was a significant difference 
in biofilm production between induced and uninduced cultures at 2 µg/ml erythromycin. 
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Further replicates are needed to confirm this result, as no significant differences in 
biofilm production between induced and uninduced cultures was observed at 0, 1, 4 and 6 
µg/ml, which is expected because no proteins are under induction control, suggesting the 
change at 2 µg/ml may be artifactual.     
   PA051(OpmH expressing) also demonstrated an increase in biofilm production in 
a dose dependent fashion as concentrations of erythromycin increased, with the exception 
of 6 µg/ml in uninduced cells, which actually produced significantly less biofilm (Figure 
10c). Unlike PA050, PA051 increases expression of OpmH upon induction, and curiously 
induction of OpmH led to a significant 1.7-fold (p=0.002), and 1.8-fold (p=0.01) decrease 
in biofilm production at 2 and 4 µg/ml erythromycin respectively. This data suggests that 
OpmH expression decreases biofilm production. The decrease in biofilm production 
could be caused by MexJK-OpmH efflux of quorum sensing molecules which have been 
shown to accumulate during biofilm production (de Kievit, 2009), as the antibiotic itself 
is not compatible with OpmH mediated efflux. At 6 µg/ml erythromycin, this trend 
reversed and the induced cultures produced a significant 8.1-fold (p=0.0005) increase in 
biofilm, which was hypothesized to be a result of growth inhibition in the uninduced 
culture. Taken together, this data supports a role for OpmH in biofilm production when 
P. aeruginosa is grown in the presence of erythromycin. Although mechanistic studies 
were not performed, it is hypothesized that OpmH is contributing to cell-to-cell 
communication, as erythromycin is not a substrate for MexJK-OpmH efflux. 
 In the absence of erythromycin, PA058 (OprM expressing) demonstrated 
significantly higher levels of biofilm production compared to the other strains which were 
tested. In the presence of erythromycin, PA058 behaved similarly to both PA050 and 
PA051, showing dose dependant increases in biofilm production as erythromycin 
concentration increased, however, unlike PA051, no significant differences were detected 
upon induction (Figure 10d). PA058 was capable of producing more biofilm in the 
absence of erythromycin than both PA050 and PA051, this trend was also maintained in 
the presence of erythromycin. 
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Figure 9. Protein Expression Analysis from Membrane Protein Preparation 
Demonstrating Protein Expression of MexK. Membrane protein analysis from P. 
aeruginosa PA0702 cells containing MexJK were grown to A600nm of 1.0 as described in 
the Materials and Methods. (a) SDS-PAGE.  Membrane proteins were isolated as 
described in the Materials and Methods and subjected to denaturing 12% SDS-PAGE and 
stained with CBB. Membrane proteins from PA01 (which does not normally express 
MexJK) was included as a negative control and whole cell lysate from PA0238-1 (Wild 
type expression of MexJK) was included as a positive control. Arrow indicates the 
expected migration position for MexK. (b)Immunoblot. Immunoblot was probed with a 
1:20000 dilution of polyclonal rabbit α-MexK antibody, and subsequently probed with a 


























Table 5. Antibiotic Susceptibility Profile. Minimum inhibitory concentrations for 
Triclosan and Erythromycin, substrates for MexJK-OpmH (PA051) and MexJK-OprM 
(PA058) respectively were determined according to the CLSI standards as described in 
the Materials and Methods. MIC values represent the lowest concentration of antibiotic 
or compound required to inhibit growth of bacteria. The agar dilution method was used to 
determine triclosan MIC. The broth dilution method was used to determine the 








-IPTG +IPTG Fold Change -IPTG +IPTG Fold Change 
PA050 MexJ, MexK 2 2 No Change 4 4 No Change  
PA051 MexJ, MexK, 
OpmH 
4 32 8-fold 4 4 No Change 
PA058 MexJ, MexK, 
OprM 
4 4 No Change 2 8 4-fold 
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Figure 10. The Effect of MexJK-OpmH/OprM on Biofilm Formation in P. 
aeruginosa Constructs Containing Different Outer Membrane Components (a) 







(MexJK-OpmH), and PA058 (MexJK-OprM) were determined +/- induction with 1.0 
mM IPTG as discussed in the Materials and Methods. In the presence of IPTG, data is 
represented as mean±standard deviation, p=0.05 for IPTG- and p=0.0004 for IPTG+. 
Biofilm was assessed in the same fashion as (a) however, various concentrations of 
erythromycin during biofilm formation were also assessed. Erythromycin concentrations 
of 1.0, 2.0, 4.0, and 6.0 μg/ml were used for strains PA050 (b), PA051 (c), and PA058 
(d), which have no outer membrane RND protein, inducible OpmH, and inducible OprM 
respectively. Data shown is representative of a minimum of two biological replicates. 
Bars represent the mean ± standard deviation, and statistical analysis was performed 












While the introduction of oprM in PA050 resulted in an increase in biofilm, no 
significant difference was observed upon induction of the oprM gene compared to when 
it was not induced.  It is not clear why we did not observe a further increase in biofilm 
formation upon the induction of oprM when the mere presence of this gene causes an 
increased biofilm formation and further investigation is necessary to study the reasons 
thereof. 
 P. aeruginosa is notorious for biofilm production, which is important during 
infection, and in some environmental systems. The data reported here demonstrates that 
the outer membrane RND protein in complex with MexJK is important for biofilm 
production. The strain containing OprM was capable of generating more biofilm than the 
OpmH containing strain, which produced more biofilm than the strain lacking both. 
Curiously though, OprM induction did not significantly affect biofilm production in the 
presence of erythromycin, whereas, OpmH induction led to a decrease in biofilm 
production in the presence of erythromycin, suggesting a possible role in cell-to-cell 
communications. Further investigation is required to completely assess the role of the 
MexJK outer membrane protein in biofilm production.            
  The outer membrane component of MexJK-OprM/OpmH had a strong effect on 
P. aeruginosa biofilm production, which was amplified in the presence of erythromycin. 
These observations led us to examine the effects of erythromycin on the production of 
biofilm with a variety of strains containing deletions of various RND efflux components 
(Figure 11). Wild-type P. aeruginosa PA01 demonstrated a significantly decreased 
capacity to produce biofilm in the presence of 6 µg/ml erythromycin when compared to 
biofilm production in the absence of erythromycin (Figure 11) which was expected based 
on the observations of others (Kondoh and Hashiba, 1998). All of the deletion strains 
tested showed significantly enhanced biofilm formation in the presence of erythromycin. 
In the absence of erythromycin, none of these strains generated significantly different 
biofilm when compared to each other.  
 Taken together, this data demonstrates that the RND efflux pumps have important 
roles when P. aeruginosa encounters antibiotics, particularly erythromycin. RND efflux 
pumps are not only capable of enhancing survival through efflux of antibiotic molecules, 
but may also play a role in mediating biofilm formation during erythromycin treatment. 
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Wild-type strains reduce the amount of biofilm production in the presence of 
erythromycin. However, strains deficient in one or more component of the RND efflux 
complexes typically generated more biofilm in the presence of erythromycin, possibly 
implicating a complex compensation mechanism, as biofilm has been shown to enhance 
antibiotic resistance (Hoiby, et al., 2011). Biofilm production has been linked to quorum 
sensing, and it is possible that when the efflux pumps are absent, erythromycin 
accumulates within the cell, enhancing signaling molecule production. These signaling 
molecules cannot be secreted due to various deletions in the efflux components, and 
therefore they positively regulate biofilm production within the cell.   
ii. Bioassay for AHL Secretion 
 RND efflux pumps have been associated with cell-to-cell communications, 
through their ability to efflux quorum sensing molecules (Alvarex-Ortega, et al., 2013). 
Here, we demonstrate that multiple strains with differing efflux pump compositions were 
capable of effluxing AHLs. Various P. aeruginosa strains were grown next to E. coli 
MT102 which harbours the plasmid pJBA132, an AHL reporter plasmid which expresses 
GFP when exposed to AHL. The presence of increased fluorescence indicates increased 
secretion of AHL by the P. aeruginosa strain. Strains PA01, PA050, PA051, PA058, 
PA0702 and PA01172 all demonstrated secretion of the AHL, which was apparent by the 
green fluorescence at the tip of the reporter E. coli streak (Figures 12a-d, g, and h). 
PA0200 and PA0238 were not capable of inducing GFP expression in the E. coli reporter 
(Figure 12e and f) indicating they did not secrete AHL into the medium. This result 
remains somewhat convoluted, as PA0200 and PA0238 have deletions in MexAB-OprM 
(PA0200), or MexAB-OprM and MexCD-OprJ (PA0238). The common factor between 
these strains is the deletion in MexAB-OprM, however, MexAB-OprM is deleted in all 
other strains tested except PA01, suggesting some other causative agent is responsible.    
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Figure 11. Erythromycin Affects Biofilm Formation in P. aeruginosa Isolates. The 
effect of erythromycin on biofilm formation using 6.0 μg/mL was measured on P. 
aeruginosa strains harbouring RND pump knockouts. Data shown is representative of a 
minimum of two biological replicates. Bars represent the mean ± standard deviation, and 










Figure 12. Bioassay for AHL Secretion. E. coli strain harbouring the reporter plasmid 
pJBA132 which produces GFP if exposed to AHL were streaked vertically. P. 
aeruginosa strains PA01, PA050, PA051, PA058, PA0200, PA0238, PA0702, and 
PA01172 were streaked horizontally and green fluorescence at the junction between the 
sample and the reporter was monitored with a blue light transilluminator. Data shown is 








iii.  Swimming and Swarming Motility 
 Swimming motility was analyzed with and without the addition of 6 µg/ml 
erythromycin. In P. aeruginosa a single, polar flagellum is thought to drive swimming 
motility (Murray and Kazmierczak, 2006) independently of cell-to-cell communications 
(O'May and Tufenkji, 2011). All strains tested demonstrated swimming motility in the 
presence or absence of 6 µg/ml erythromycin (Figure 13). In the absence of erythromycin 
wild-type PA01 demonstrated limited controlled swimming in a characteristic circular 
pattern. However, when swimming was assessed in the presence of 6 µg/ml erythromycin 
PA01 demonstrated enhanced motility, and sporadic growth reaching the perimeter of the 
plate. PA050 (lacking OpmH, MexAB-OprM, MexXY, MexCD-OprJ, with mini-Tn7-
lac), PA0702 (lacking OpmH, MexAB-OprM, MexXY, MexCD-OprJ), and PA01172 
(lacking MexAB-OprM, MexCD-OprJ, MexJK, MexEF-OprN, MexXY, OpmH, and 
TriABC) swimming motility was relatively unaffected when compared to PA01. 
Noteably, PA050, showed unorganized outgrowth in the absence of erythromycin when 
compared to samples grown in the presence of erythromycin. Also a green pigment, 
which is assumed to be pyocyanin, a toxin and quorum sensing molecule (Gunaratnam, et 
al., 2011), appeared to be enriched in the presence of erythromycin, particularly in 
PA01172, which may be a stress response to erythromycin. Quantification of pyocyanin 
production would be required to support this hypothesis.   
 Swarming motility was also analyzed with and without the addition of 6 µg/ml 
erythromycin. In contrast to swimming motility, swarming motility in P. aeruginosa is a 
community behavior, requiring quorum sensing, which allows the bacterium to 
effectively work together to promote organized flagellum-dependent motility on surfaces 
(Murray and Kazmierczak, 2006). Unlike swimming, which uses a single polar flagellum 
for motility, swarming is associated with multiple, lateral flagella (Bardy, et al., 2000) in 
the majority of bacterium. In P. aeruginosa swarming is accomplished through twitching 
motility, usually by two polar flagella (Kohler, et al., 2000), however, type IV pili have 
also been shown to contribute (Mattick, 2002). In the absence of erythromycin all strains 
demonstrated out-growth, however, this growth did not appear organized, and resembled 
swimming (Figure 14). Curiously, wild-type PA01 did not appear to swarm, however, 
PA050 (lacking OpmH, MexAB-OprM, MexXY, MexCD-OprJ, with mini-Tn7 lac), 
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PA0702 (lacking OpmH, MexAB-OprM, MexXY, MexCD-OprJ), and PA01172 (lacking 
MexAB-OprM, MexCD-OprJ, MexJK, MexEF-OprN, MexXY, OpmH, and TriABC) 
demonstrated characteristic dendritic fractal-like growth indicating effective, organized, 
quorum sensing was taking place. This was expected because the RND efflux pumps are 
associated with efflux of quorum sensing molecules which limits their effectiveness. 
Although further experimentation is required, it appears that MexJK-OprM/OpmH may 
have an important role in quorum sensing molecule efflux, as all strains which lack a 
functioning MexJK-OprM/OpmH complex showed increased swarming motility which 
suggests an increase in quorum sensing, under antibiotic stress with 6 µg/ml 
erythromycin.   
 
C.  Domain Swapping Experiment 
 Triclosan, a commonly used biocide in household products, is quickly becoming 
ineffective against several strains of P. aeruginosa in part because of this bacterium’s 
ability to actively efflux the molecule. Triclosan inhibits a highly conserved enzyme 
enoyl-ACP reductase (FabI) which is involved in bacterial fatty-acid biosynthesis (Heath 
and Rock, 2000). Triclosan is becoming ubiquitous in the environment, and is of 
particular concern in wastewater as the rate of species resistant to this biocide continues 
to grow. MexJK-OpmH is capable of triclosan efflux and we sought to identify the 
domains within OpmH that are responsible for triclosan efflux, and therefore resistance. 
i. Creation of the chimeras: 
 Creation of the chimeras was carried out by performing a PCR-based domain 
swapping protocol (Elkins and Nikaido, 2002) followed by inserting the His-tagged genes 
into the chromosome of P. aeruginosa PAO702 cells, as described in the Materials and 
Methods. PCR was performed in order to confirm the successful swap of the domains. 
For reference, primer binding sites are highlighted in Figure 15a. PCR products for the 
primers were run out on a 0.8% agarose gel in Figure 15b confirming that domain 1 and 
domain 2, which correlates to helix 1 and 3, respectively, were inserted (also confirmed 
by sequencing; see Figure 16). A unique set of primers was used to confirm insertion of 
the   
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Figure 13. The Effect of Erythromycin on Swimming Motility of Various P. 
aeruginosa Strains with Deletions in their RND Efflux Components. Swimming 
zones were measured after 48 hours on 0.3% LB agar plates with or without 6 µg/ml 
erythromycin as discussed in the Materials and Methods. PA01, PA050, PA0702, 
PA01172, PA01 with erythromycin, PA050 with erythromycin, PA0702 with 
erythromycin, and PA01172 with erythromycin were analyzed. Data shown is 



















Figure 14. The Effect of Erythromycin on Swarming Motility of Various P. 
aeruginosa Strains with Deletions in their RND Efflux Components. Swarming zones 
were measured after 48h on 0.5% LB agar plates with or without 6 µg/ml erythromycin 
as discussed in the Materials and Methods. PA01, PA050, PA0702, PA01172, PA01 
with erythromycin, PA050 with erythromycin, PA0702 with erythromycin, and 
PA01172 with erythromycin were analyzed. Data shown is representative of a minimum 
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Figure 15. Verification of the Various Domains of the OprM/OpmH Chimeras by 
0.8% Agarose Gel Electrophoresis of PCR products. (a) Panel B primer binding 
sites. To simplify, primer binding sites are denoted in Panel A. (b) Verification of 
domain 1, domain 2 and domain 1 and 2 insertion. Sample 'Helix 1' contains an 
OpmH insert at the Helix 1 position of OprM (5' end; domain 1), sample 'Helix 3' 
contains an OpmH insert at the Helix 3 position of OprM (3' end; domain 2), and sample 
'Helix1:3' is a hybrid containing an OpmH insert at both Helix 1 and Helix 3 (domains 1 
and 2). PCR products using the various primer sets are denoted in Panel B (oprM_T117F 
and OprM_E481R 1100 bp amplicon (Panel A: primer set A(also sequencing primers)); 
OprM_A200R and opmH_L164F 148 bp amplicon (Panel A: Primer set B); 
oprM_R426F and opmH_N409R 142bp amplicon (Panel A: Primer set C). (c) 
Verification of the chimera spanning from the beginning of domain 1 to the end of 
the domain 2 insert. Samples '1-4' and '5-8' are replicates, sample '9' is a no template 
control. Sample '1-4' are a 292 bp amplicon of the mini-Tn7 vector, confirming insertion 
into P. aeruginosa chromosome (primers: Tn7R_Fwd and Pa_glmS_Rev), and samples 
'5-8' are a 1800 bp amplicon spanning from the 5' OprM region to the 3' OpmH region 


















hybrid spanning domain 1 to 2, or helix 1 to 3 respectively (Figure 15c; also confirmed 
by sequencing; see Figure 16). 
ii. Sequencing Analysis 
 The swapped domains were amplified using PCR from all four strains harbouring 
chimeras and the products were sequenced at Genome Quebec Facility, McGill 
University (Montreal, QC) (Figure 16a-d) to confirm the constructs.  
iii. Hypothetical Homology Models 
 Hypothetical homology models of the monomeric component of the homo-
trimeric structure were generated using Protein homology/analog Y recognition engine V 
2.0 (Phyre2), using the PHYRE2 Protein Fold Recognition Server 
(www.sbg.bio.ic.ac.uk/phyre2/ ), displaying the location of the swapped domains (Figure 
17a), and the domain's origin (Figure 17b). Site-directed mutagenesis studies were 
previously performed by Poole (Nehme and Poole, 2007) and were included for reference 
(Figure 17c). Models were also generated showing the location of the helix 1 swap 
(domain 1), the helix 3 swap (domain 2), swapping both helix 1 and 3 (domain 1 and 2) 
together and swapping the residues from helix 1 to helix 3 (domain 1 star to domain 2 




Figure 16. Sequencing Results of Chimeras Harbouring Swapped Domains. 
Highlighted regions represent region swapped. (a) Single domain (Domain 1) swapped 
in helix 1. (b) Single domain (Domain 2) swapped in helix 3. (c) Both domains 
(Domain 1 and 2) swapped in helices 1 and 3. (d) Domains in helices 1 and 3 were 
















































































Figure 17. Homology Models of Chimeras Harbouring Swapped Domains. The 
chimeras were modelled using P. aeruginosa’s OprM as a template as described in the 
Materials and Methods. Helix 1 swap is represented by blue, helix three swap is 
represented by red and the region located between the two helices is represented by 
green. (a) Native OprM. (b) Native OpmH (c) Reference: mutated residues within OprM 
(Nehme and Poole, 2007) (d) Structure showing Helix 1 swap (Domain 1). (e) Structure 
showing helix 3 swapped (Domain 2). (f) Structure showing helices 1 and 3 swapped 
together (Domain 1 and 2). (g) Structure showing helices 1 and 3 including the area 
between them swapped (Domain 1 to Domain 2). OM stands for outer membrane and PP 
stands for periplasm. 
















iv. Insertion of Chimeras into P. aeruginosa Single-copy Vectors 
 Insertion of the vector backbone and removal of the Gm resistance gene cassette 
was confirmed by PCR (Figure 18). Expression of this system was confirmed by SDS-
PAGE and immunoblotting as described in Figure 19. 
D. Phenotypic Analysis of Strains Harbouring Chimeras 
i. Antibiotic Susceptibility Profile 
 The phenotypic verification of the constructs was analyzed through antibiotic 
susceptibility assays where the MIC for each strain was determined by either broth 
dilution (erythromycin), disc-diffusion (erythromycin) or agar dilution (triclosan) 
methods according to the CLSI guidelines. The MexJK-OprM complex has been shown 
to efflux erythromycin but not triclosan; therefore resistance to erythromycin was used as 
an indicator of a functional MexJK-OprM complex being formed. Alternatively, the 
MexJK-OpmH complex has been shown to efflux triclosan but not erythromycin; 
therefore resistance to triclosan was used as an indicator of a functional MexJK-OpmH 
complex being formed.  
 P. aeruginosa strain PA058 harboring MexJK-OprM, displayed resistance to 
erythromycin (Table 6) with a 4-fold change in MIC upon induction (4 µg/ml to 16 
µg/ml) which was similar to the change reported in Table 5 (2 µg/ml to 8 µg/ml). As 
expected, the MexJK-OpmH harboring strain, PA051, did not efflux erythromycin in an 
induction dependant manner. Erythromycin resistance was lost in the strains harbouring a 
Domain 1 swapped chimeric OprM protein (PA071, PA073 and PA074), as indicated by 
the MIC remaining at 4 µg/ml. This indicates that the amino acids contained within 
Domains 1 (192-204) and 2 (418-433) are critical for MexJK-OprM dependent efflux. 
PA072 contained a modified domain 2, which requires further investigation, as MIC 
changed to that of the induced control (16 µg/ml), in both induced and uninduced 
samples. This change could be due to active MexJK-chimericOprM efflux, or the lack of 
induction could indicate that amino acids with Domain 2 (425-440) are also critical for 
function, given that induction was confirmed to have an effect on triclosan efflux. Further   
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Figure 18. Verification of Chimera Insertion into P. aeruginosa. Insertion of mini-Tn7 
vector was assessed by PCR using primers Tn7R_Fwd and Pa_glmS_Rev (listed in Table 
3), yielding a 292bp product.  1. 100-1.5kb ladder. 2. PA071 (Domain 1). 3. PA072 








































 Table 6. Antibiotic Susceptibility Profile for Chimeras. Minimum inhibitory 
concentrations for triclosan and erythromycin, substrates for MexJK-OpmH and MexJK-
OprM respectively were determined for the chimeras harbouring the swapped domains 
according to the CLSI standards as described in the Materials and Methods. MIC values 
represent the lowest concentration of antibiotic or compound required to inhibit growth of 
bacteria. The agar dilution method was used to determine triclosan MIC, both disc 




Erythromycin  (Broth 
Dilution) 
 
Triclosan    (Agar Dilution) 
 
 -IPTG +IPTG Fold-change -IPTG +IPTG Fold-change 
PA071 MexJ,MexK, 
OprM, Helix 1 
4 4 No Change 2 2 No Change 
PA072 MexJ, MexK, 
OprM, Helix 3 
16 16 No Change 2 8 4-fold 
PA073 MexJ, MexK, 
OprM, Helix 1 
to Helix 3 
4 4 No Change 2 2 No Change 
PA074 MexJ, MexK, 
OprM, Helix 1 
and Helix 3 
4 4 No Change 2 2 No Change 
PA050 MexJ, MexK 
only 
8 8 No Change 2 2 No Change 
PA051 MexJ, MexK, 
OpmH 
4 4 No Change 4 32 8-fold 
PA058 MexJ, MexK, 
OprM 
4 16 4-fold 2 2 No Change 
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experimentation is required to elucidate the mechanism responsible for the changes in 
MIC, and to specifically pinpoint which amino acids are critical to erythromycin efflux. 
 Conversely, P. aeruginosa strains PA051 harboring MexJK-OpmH, displayed 
resistance to triclosan with an 8-fold change in MIC upon induction (4 µg/ml to 32 
µg/ml) which was identical to the 8- fold change reported in Table 5 (4 µg/ml to 32 
µg/ml), however, it should be noted that some variability in triclosan MIC replicates was 
observed, and up to 32-fold changes in MIC were occasionally seen (2 µg/ml to 64 
µg/ml) (Appendix F), perhaps because triclosan MIC must be performed on solid media, 
making standard serial dilutions impractical. All other strains (PA071, PA073, PA074, 
PA050, PA058) except PA072 were not capable of increased triclosan resistance, under 
inducing or noninducing conditions. The MexJK-chimeric OprM PA072 strain has amino 
acids 418-433 of the OprM protein (DKRYRTGVDNYLTLLD) replaced with OpmH 
amino acids 425-440 (GTRNIVDVLNAQRQLY), and showed a 4-fold increase in 
triclosan resistance upon induction (2 µg/ml to 8 µg/ml) in a reproducible fashion. 
MexJK dependant efflux of triclosan was previously thought to be OpmH dependent, 
however, for the first time a chimericOprM protein is reported to also be capable of 
triclosan efflux in connection with the MexJK complex. The wild type phenotype was not 
completely restored, suggesting that the chimeric OprM protein is not as effective as 
OpmH at triclosan efflux. Helix 3 of OpmH/OprM appears to play a critical role for 
substrate specificity and efficiency of the MexJK pump, possibly implicating it as a 
binding site between components, or as a critical component in channel orientation.  
ii. Protein Expression Analysis 
 SDS-PAGE with CBB staining demonstrated a 50 kDa protein band 
corresponding to the expected molecular weight of OprM/OpmH for all strains (Figure 
19a). Upon induction of OprM and probing with an α-OprM antibody a band could be 
seen at approximately 50 kDa from P. aeruginosa strains PA058, PA072 and PA074 
(harbouring wild type or chimeric OprM) but not PA071 and PA073 (harbouring 
chimeric OprM with swapped domain 1 or swapped domain 1 to domain 2). This 
indicated that modification to domain 1 may destabilize the protein, or interfere with its 
transport to the membrane. It is also possible that domain 1 is required for epitope 
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recognition by the antibody, however, the fact that PA074, a strain containing swapped 





Figure 19. Protein Expression Analysis from Whole Cell Lysate Demonstrating 
OprM. Whole cell lysate analysis from P. aeruginosa PA0702 cells harbouring swapped 
domains were grown to A600nm of 0.6, induced (1.0 mM IPTG) and harvested at A600nm of 
1.0 as described in the Materials and Methods. (a) SDS-PAGE.  Whole cell lysates were 
analysed on a denaturing 12% SDS-PAGE, membrane protein from PA058 +1.0 mM 
IPTG was included as a positive control. Arrow indicates the expected migration position 
for OprM. (b) Immunoblot. Immunoblot was carried out using a 1:10000 dilution of 
purified rabbit α-OprM primary antibody, and subsequently probed with a 1:20000 






































A. Antimicrobial Resistance and P. aeruginosa 
 The discovery of antibiotics was one of the most influential breakthroughs of 
modern medicine. So much so that it led the 1967 Surgeon General William H. Steward 
to proclaim that "the war against infectious diseases has been won" (Upshur, 2008). 
However, the gross misuse of antibiotics has given rise to an epidemic of antibiotic 
resistance, so much so, that the science ministers at the G8 world leader's summit have 
proclaimed that antimicrobial drug resistance will be a major health security challenge in 
the 21st century (Hunt, 2013).    
 The increasing prevalence of RND efflux pumps and their ability to pump out a 
wide range of antimicrobial substrates make them particularly important to study as 
antimicrobial resistance agents. Different RND efflux pumps from Gram-negative 
pathogens such as P. aeruginosa, E. coli and A. baumannii have been identified which in 
combination efflux all classes of clinically relevant natural, semi-synthetic, and 
completely synthetic antibiotics (Wright, 2005). All outer membrane proteins within the 
RND efflux protein family are trimeric with each protomer having a long β-barrel domain 
anchored to the outer membrane and a long α-helical domain containing 12 coiled coils 
projecting into the periplasm (Blair and Piddock, 2009). The majority of RND efflux 
complexes have a broad substrate range, making the mechanisms of efflux challenging to 
study. However, there are some pump complexes such as the MexJK-OprM and the 
MexJK-OpmH complex that have narrow substrate specificity. It is this characteristic that 
makes MexJK-OprM/OpmH ideal for studying how RND efflux pumps recognize their 
substrates. 
 P. aeruginosa is a Gram-negative opportunistic pathogen, prevalent in 
nosocomial infections particularly in patients suffering from cystic fibrosis (Davies, 
2002). The success of P. aeruginosa as a nosocomial pathogen can be attributed to its 
intrinsic resistance to several antimicrobial agents including antibiotics, biocides and 
heavy metals. Multidrug efflux systems significantly contribute to this intrinsic multidrug 
resistance of P. aeruginosa, and in the clinic this has promoted enhanced acquired 
multidrug resistance. These pumps are able to export not only antibiotics, but dyes, 
detergents, disinfectants and homoserine lactones involved in quorum sensing 
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(Lamarche, et al., 2011). An increased understanding of how the RND efflux pumps of P. 
aeruginosa function is critical given their clinical significance and roles in antibiotic 
resistance.  
B. Single-Copy Expression System 
 Rather than using a multi-copy expression system, which may give rise to 
artificial or sometimes even lethal phenotypes; the construction of a single-copy 
expression system to incorporate and express the target gene was chosen because it more 
accurately represents protein levels that are biologically relevant to the cell. Choi et al. 
designed a single-copy system utilizing the Tn7 bacterial transposon which is capable of 
transposition into the bacterial chromosome at the neutral Tn7 attachment site (attTn7) 
(Choi, et al., 2005). We have used this system to express the efflux components OprM 
and OpmH along with several chimeric proteins containing combinations of the two, in 
an attempt to better understand how these proteins operate within the MexJK-
OprM/OpmH system.  
 To assess the expression of the outer membrane protein OprM, along with the 
RND-transport protein MexK, qRT-PCR was used. As expected, qRT-PCR indicated 
levels of OprM mRNA which was comparable with another single copy system, OpmH, 
reported from our laboratory (Ganeshanantham, 2011) and were approximately 5-fold 
lower than multi-copy OpmH expression systems (Ganeshanantham, 2011).  
 The parent strain PA0702 for which OprM and OpmH were inserted; 
constitutively overexpresses MexK. qRT-PCR of MexK demonstrated 15-fold higher 
transcription for PA051 (OpmH) and PA058 (OprM) compared to PA01 which expresses 
native levels of MexK (Figure 6a). Induction of OpmH resulted in a 20-fold increase in 
expression (Ganeshanantham, 2011) and a 30-fold increase in expression of OprM when 
compared to uninduced cells (Figure 6b). Taken together these results indicate that the 
single copy systems were functional, and although they still produce relatively higher 
levels of the desired transcript, they are capable of more closely imitating the natural 
biological system.  
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 Protein analysis by SDS-PAGE and CBB staining demonstrated an approximately 
50 kDa protein which correlates to the expected size of the outer membrane protein 
OprM (50 kDa), after membrane protein isolation (Figure 7a). After probing with rabbit 
α-OprM antibodies a band correlating to OprM was observed in PA058, a strain 
constructed to express OprM from a single copy vector (Figure 7b). A 50 kDa band 
correlating to OpmH was also observed by SDS-PAGE with CBB staining in PA051 
(Figure 8a), a strain constructed to express OpmH from a single copy vector. Also, a band 
correlating to OpmH after probing with goat α-OpmH antibodies was observed (Figure 
8b). The band correlating to OpmH was faint, because as antibody concentration 
increased, non-specific binding also increased, making procedure optimization 
challenging. SDS-PAGE and CBB staining revealed a protein of 100-120 kDa which 
correlates to MexK (Figure 9a). After partial purification of goat α-MexK antibodies 
from blood, a 100-120 kDa protein correlating to MexK was also observed with 
immunoblotting of membrane proteins from PA051 and PA058 which both constitutively 
express MexK (Figures 9a and 9b). In combination with the qRT-PCR data described 
above, this data demonstrates that the single-copy expression systems designed in this 
study, to analyze the outer membrane proteins OpmH and OprM in the MexJK-
OpmH/OprM complex is completely functional. mRNA transcripts were elevated 
compared to wild type expression levels, however, not to the extent of multi-copy 
systems, and the transcribed message was being translated into protein which migrated to 
the membrane. This system provides several advantages over traditional multi-copy 
systems. 
 Traditional multi-copy systems were developed for high levels of gene expression 
from plasmids, which is often desirable particularly if one intends on purifying the 
protein being expressed. However, if protein purification is not the goal of a particular 
study, overproduction of protein may generate undesired phenotypes, such as decreased 
growth rate, induction of stress responses, and altered properties of the protein itself, 
resulting in observations which may not be physiologically relevant, and hence 
misleading (Boyd, et al., 2000). This is particularly important when studying the RND 
efflux complex, as the pumps activity is measured in vivo using assays such as MIC. 
Overexpression of the RND efflux proteins may result in loss of cell viability, or artifacts 
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that may convolute the natural phenotype. In an attempt to avoid the negative 
complications associated with multi-copy gene expression systems, we developed a 
single copy system which is particularly accommodative for studying the outer 
membrane components of the MexJK-OprM/OpmH efflux pump, with marked reduction 
in expression levels compared to more traditional multi-copy systems. In these systems, 
the outer membrane protein (OprM or OpmH) may be induced allowing specifically for 
the study of its role in the RND complex. The membrane fusion protein MexJ and the 
resistance nodulation division transporter protein MexK are constitutively expressed, 
remaining constant amongst the strains.      
 As a final confirmation, antibiotic susceptibility data was compared, and indicated 
that these strains are able to form functional complexes capable of efflux; promoting a 
resistant phenotype. Upon induction of the outer membrane proteins of the MexJK-OprM 
complex there was a 4-fold increase in erythromycin MIC compared to uninduced 
cultures and an 8-fold increase in triclosan MIC after induction of the outer membrane 
protein of the MexJK-OpmH complex compared to uninduced cultures (Table 5). The 
enhancement of MIC after induction of the outer membrane protein is indicative of 
functional complex formation with MexJK. These functional complexes were capable of 
erythromycin efflux (OprM) or triclosan efflux (OpmH). Others have reported 
comparable findings after induction of a single copy vector containing OpmH (4-fold 
increase triclosan vs. 8-fold in this study), and OprM (3-fold increase in triclosan vs. 8-
fold in this study) (Chuanchuen, et al., 2005).  
 Taken together this data demonstrates successful construction of a single copy 
expression system for the analysis of OprM/OpmH in the MexJK-OprM/OpmH RND 
efflux complex. Transcripts from the various RND components were measured, and 
although elevated compared to wild-type expression levels, were more representative of 
the biological system than traditional multi-copy systems. Translation of the transcripts 
and migration of the protein to the membrane fraction of the cell was also confirmed. 
Finally, the activity of the MexJK-OprM/OpmH complexes were measured using MIC, 
and conclusively demonstrated functional complex formation, as the strains were able to 
efflux the expected antibiotic in an inducible fashion.     
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C.  P. aeruginosa Virulence 
i. Biofilm Formation 
 Biofilms are surface-associated microbial communities in which the cells are 
typically encased in an extracellular matrix composed of DNA, RNA, protein, and 
polysaccharides (Ma, et al., 2009). Biofilms have broad reaching importance, not only in 
the clinic but also in the environment, as they may adhere to either biotic (i.e. patient) or 
an abiotic (i.e. water pipe) surfaces (Flemming and Wingender, 2010). P. aeruginosa 
biofilms are particularly important in the cystic fibrosis lung, allowing for permanent 
colonization, even through aggressive antibiotic treatment (Singh et al., 2000). Biofilm 
production during infection is associated with an increase in antimicrobial resistance. 
Several mechanisms have been reportedly responsible for the enhanced antimicrobial 
resistance within the biofilm structure. (1) Biofilms decrease the permeability of most 
antibiotics through the polysaccharide matrix (Anderl, et al., 2000). (2) Biofilms cause 
physiological changes such as decreased growth rate and starvation responses which are 
associated with enhanced resistance (Brown, et al., 1988; Walters, et al, 2003). (3) 
Biofilms enhance the expression of efflux pumps within the matrix (Gilbert, et al., 2002), 
and (4) enhance survival of persistor cells within the matrix (Lewis, et al., 2007), 
something which is particularly important in P. aeruginosa infections in the cystic 
fibrosis lung, where complete erradication has proven almost impossible in some 
patients. Quorum sensing has been shown to be critical to effective biofilm production 
(Brooun, et al., 2000), and quorum sensing inhibitors are currently being explored as an 
attractive therapeutic which may limit biofilm production during P. aeruginosa infection 
of the cystic fibrosis lung (Jakobsen, et al., 2013), thereby making them more susceptible 
to antibiotic therapies.   
 The MDR RND efflux pumps of P. aeruginosa play an important role in the 
antibiotic resistance of non-biofilm associated planktonic cells, and are also important in 
P. aeruginosa biofilm associated cells, exhibiting resistance to all classes of 
antimicrobials. Aside from an important role in antimicrobial resistance, RND efflux 
pumps also have a role in influencing biofilm production in several organisms including 
P. aeruginosa. The RND efflux pumps MexAB-OprM (Evans, et al., 1998) and MexEF-
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OprN (Lamarche and Deziel, 2011) are able to efflux AI molecules, which are critical to 
quorum sensing and biofilm production (Miller and Basser, 2001). Curiously, strains 
which overexpress these pumps show a decrease in AI molecule accumulation within the 
cell, causing downstream effects, such as attenuated virulence and a reduced capacity to 
form biofilms (Minagawa, et al., 2012). To date, the role of the MexJK-OprM/OpmH 
RND efflux pump on biofilm formation has not been evaluated. Therefore, we sought to 
determine the role of MexJK-OprM/OpmH on biofilm production using the single copy 
construct (PA050, PA051 and PA058). A variety of P. aeruginosa strains containing 
alternative RND efflux pump compositions were used to more generally assess the role of 
RND efflux pumps on biofilm production. 
 Upon induction of OpmH from PA051, biofilm formation was shown to be 
significantly increased when compared to the uninduced cells or the MexJK only strain 
(PA050) which does not contain an RND outer membrane protein (Figure 10a). Upon 
induction of OprM from PA058, biofilm formation was shown to be significantly 
increased when compared to the empty strain PA050 (Figure 10a). PA058 was also 
capable of producing significantly more biofilm than both PA050 and PA051 suggesting 
that MexJK-OprM contributes more effectively to biofilm production than MexJK-
OpmH (Figure 10a).  
 Long-term erythromycin treatment (up to 80 days) has been proposed to treat 
diffuse panbronchiolitis, a chronic lower respiratory tract infection associated with 
persistent P. aeruginosa infection in the cystic fibrosis lung, because it reduces biofilm 
formation (Naqata et al., 2004). Here we assessed the role of MexJK-OpmH/OprM in 
biofilm production grown in the presence of varying concentrations of erythromycin. 
Contrary to the findings of Nagata et al. in wild-type P. aeruginosa, we observed 
significant increases in biofilm production in all of our constructed strains, which 
increased in an apparent dose dependant fashion with increasing concentration of 
erythromycin (Figure 10b-d). Increasing concentrations of erythromycin led to increased 
biofilm production in PA050, a strain which lacks OpmH or OprM, however, this effect 
appeared to be more pronounced in PA051 and PA058, strains containing OpmH and 
OprM respectively. Curiously, PA058 did not show any significant differences after 
94 
 
induction of OprM, however, induction of OpmH in PA051 led to significant differences 
in biofilm production at 2, 4, and 6 µg/ml (Figure 10 c). At 2 and 4 µg/ml erythromycin, 
PA051 biofilm production was significantly decreased. Efflux of quorum sensing 
molecules by RND efflux pumps has been shown to limit the accumulation of quorum 
sensing molecules within the cell which results in decreased biofilm production 
(Lamarche and Deziel, 2011). Therefore, our results suggest that the MexJK-OpmH 
pump may be involved in the efflux of quorum sensing molecules because after induction 
of OpmH there was a decrease in biofilm production. At 6 µg/ml erythromycin, biofilm 
production was significantly enhanced upon induction, which is likely a result of 
enhanced cell viability, because the uninduced strain would be unlikely to survive at this 
concentration given our previously reported MIC of 4 µg/ml (Table 5). The role of the 
MexJK-OprM/OpmH efflux pump on biofilm production remain somewhat convoluted 
by the fact that there were no significant differences upon induction of the respective 
pumps except with erythromycin treatment of PA051, which implicates other important 
contributing factors. This in combination with the relatively non-specific nature of the 
assay leaves several questions as to the specific role of OpmH and OprM, which must be 
addressed in additional studies.    
 Antimicrobials are consistently found at low, sub-inhibitory concentrations within 
the soil. However, these concentrations are typically not at critical concentrations 
required for complete inhibition of microbial growth. This observation has led to the 
hypothesis that antibiotics have alternative roles which are dependent on their 
concentration. At lower concentrations antibiotics may be acting as signalling molecules 
and are able to modulate gene expression, whereas at clinically relevant higher 
concentrations they may inhibit a variety of processes (Davies et al., 2006; Fajardo and 
Martinez, 2008). Erythromycin is an antibiotic used to treat non-cystic fibrosis infections 
in the lung such as bronchiectasis (a condition characterized by damage and scarring to 
the airway) (Serisier, et al., 2013) and has also been explored as a biofilm reducing agent 
for P. aeruginosa infections (Naqata, et al., 2004). Infections of the lung are known to be 
polymicrobial, and may contain both Gram-positive and Gram-negative organisms. 
Erythromycin is an antibiotic commonly used to treat Gram-positive infections of the 
lung. Although erythromycin is not typically used to treat P. aeruginosa infections, P. 
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aeruginosa may be inadvertently exposed to erythromycin during treatment. We wanted 
to investigate whether erythromycin would enhance biofilm production in P. aeruginosa 
when treating these infections.  
 The wild-type strain PA01 displayed decreased biofilm production in the presence 
of 6 µg/ml erythromycin, compared to cells grown in the absence of erythromycin 
(Figure 11), an effect which has been observed by others (Nagata, et al., 2004). The 
parent strain PA0702 (lacking OprM/OpmH) showed a non-significant increase in 
biofilm formation upon addition of 6 µg/ml erythromycin compared to no erythromycin, 
however, strains PA0238 (lacking MexAB-OprM and MexCD-OprJ), PA01172 (lacking 
MexAB-OprM, MexCD-OprJ, MexJK, MexEF-OprN, MexXY, OpmH, and TriABC), 
and PA0200 (lacking MexAB-OprM) all showed a significant increase in biofilm 
formation with the addition of erythromycin (Figure 11). In the absence of erythromycin, 
all strains showed relatively similar biofilm production. These results are interesting and 
somewhat unexpected. Although further experimentation is required, it is tempting to 
speculate that erythromycin may upregulate RND efflux components in wild-type cells 
such as PA01 to ensure survival. The upregulation of efflux components may lead to an 
increase in the efflux of quorum sensing molecules such as AI's, and a decreased 
accumulation of biofilm generating signals within the cell. In the deletion strains, the 
opposite effect occurs, suggesting that erythromycin may actually trigger biofilm 
producing signaling molecules, and that the cell can no longer efflux the biofilm 
producing molecule, allowing for accumulation within the cell, and increased biofilm 
production. This could be a result of the MexAB-OprM pump, in those strains containing 
MexAB-OprM (PA01) biofilm production decreases in the presence of erythromycin, in 
those mutant strains (PA0702, PA0200, PA0238, PA01172) lacking MexAB-OprM, the 
cells start behaving differently in the presence of erythromycin, increasing the production 
of biofilm. 
ii. Quorum Sensing and Virulence 
 Quorum sensing is the mechanism by which single celled organisms communicate 
with one another in a fitness enhancing matter to adapt to environmental stressors (Miller 
and Bassler, 2001). Amongst P. aeruginosa isolates, evidence is accumulating which 
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implicates the RND-efflux systems as being an important component of quorum sensing, 
through efflux of quorum sensing molecules (Lamarche, et al., 2011). Quorum sensing 
has been shown to play a critical role in a variety of mechanisms which are important 
during infection, most notably in biofilm production and virulence factor regulation 
(Smith and Iglewski, 2003). This broadens the role of RND efflux pumps during 
pathogenesis, because not only are they critical to antibiotic efflux, but also important 
virulence factor modulators. In an attempt to better understand the role of MexJK-
OprM/OpmH during infection, we evaluated a potential link between expression of 
MexJK-OprM/OpmH efflux pumps and virulence of the pathogen in vitro.  
 The importance of P. aeruginosa infections have led to its use as a model 
organism for the study of biofilms (De Kievit, 2009). P. aeruginosa quorum sensing has 
been shown to play a critical role in effective biofilm formation, which was explored in 
the previous section. Three quorum sensing systems have been described for P. 
aeruginosa to date, the Las, Rhl and PQS systems. These systems rely on signalling 
molecules which are self-generated and permeable through the membrane, and when in 
complex with their receptor, coordinate gene expression in response to changes in 
population density (Mangwani, et al., 2012).  
 AHLs are a group of signalling molecules which participate in quorum sensing. It 
has been demonstrated that certain efflux pumps such as MexAB-OprM are able to 
recognize AHLs as a substrates (Pearson, et al., 1999), whereas others such as MexEF-
OprN, efflux precursor AHL molecules limiting the production of AHL in MexEF-OprN 
containing cells (Kohler, et al., 2001). To date the role of MexJK-OprM/OpmH in AHL 
efflux has not been explored, we, therefore, sought to evaluate the role of MexJK-
OprM/OpmH in AHL efflux, using a reporter strain which expresses GFP in the presence 
of the signaling molecules. Using the single copy constructs (PA050, PA051 and PA058) 
we tested the ability of MexJK-OprM/OpmH to secrete AHLs. Deletion strains were also 
compared. 
 P. aeruginosa strains were grown next to E. coli MT102 which harbours the 
plasmid pJBA132. In this system, LuxR is produced, and when in the presence of AHLs, 
binds to the LuxI promoter in a transcription activating fashion, which has been 
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engineered to control GFP production. In the absence of AHL, LuxR cannot bind to LuxI, 
and no GFP is produced. Therefore, GFP production in E. coli MT102 indicates AHL 
secretion by the test strain. Wild-type PA01, and the constructs PA050, PA051, PA058, 
harboring MexJK alone, MexJK-OpmH, and MexJK-OprM respectively all demonstrated 
AHL secretion, causing the reporter to generate GFP (Figure 12). This does not 
completely eliminate a possible role for MexJK-OprM/OpmH in AHL efflux, however, it 
does rule out efflux of a precursor AHL molecule. If an AHL precursor molecule was 
being secreted then AHL synthesis would be inhibited and no florescence would be 
expected, an effect which is observed in MexEF-OprN containing strains. Additionally, 
similar to biofilm formation, when MexAB-OprM is knocked out, the cells begin 
behaving differently, decreasing in fluorescence. Taken together, this demonstrates that 
MexJK-OprM/OpmH does not inhibit AHL synthesis via efflux of AHL precursors; 
however, there may be a role for MexAB-OprM. Further studies are required to evaluate 
whether or not MexAB-OprM or MexJK-OprM/OpmH play a role in active AHL efflux.  
iii. The role of MexJK-OprM/OpmH in P. aeruginosa motility  
 Bacterial motility is typically achieved by one of two processes either swimming, 
or swarming. Swimming in P. aeruginosa is achieved with a single polar flagellum, and 
allows for population independent movement. In contrast, swarming is a community 
behavior and in P. aeruginosa typically requires multiple flagella.  
 Previous studies have demonstrated that in flagellar bacteria which produce 
biofilms, the flagellar genes are repressed during biofilm formation. This makes sense, 
because if embedded in a biofilm matrix, a bacterium would not require motility, and 
would therefore conserve resources by limiting production of unneeded motility genes. 
This motility-to-biofilm transition has been demonstrated for Bacillus, Pseudomonas, 
Vibrio, and Escherichia (Guttenplan and Kearns, 2013). In previous experiments reported 
in this thesis, we demonstrated that erythromycin could have profound effects on P. 
aeruginosa biofilm formation, and given the apparent link between motility and biofilm 
formation, we sought to evaluate the role of the RND efflux pump MexJK-OprM/OpmH 
on swimming and swarming. 
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 All strains demonstrated swimming motility in the absence of erythromycin, 
although wild-type PA01 seemed to be somewhat limited in its capacity to swim 
compared to the other strains tested (Figure 13). With the addition of erythromycin, PA01 
demonstrated sporadic growth which was not indicative of swimming, whereas PA050 
(lacking OprM, MexAB-OprM, MexXY, MexCD-OprJ with mini-Tn7-lac), PA0702 
(lacking OprM, MexAB-OprM, MexXY, MexCD-OprJ) and PA01172 (lacking MexAB-
OprM, MexCD-OprJ, MexJK, MexEF-OprN, MexXY, OpmH, and TriABC) showed no 
obvious changes in swimming behaviour, aside from some changes in green pigment, 
which could be associated with modifications to the production of the toxin pyocyanin 
(Figure 13).  
 Swarming motility is an organized behaviour involving groups of bacteria 
traveling together. Like biofilm, swarming is prevalent during high cell density, and cells 
which participate in this particular type of mobility demonstrate increased antibiotic 
resistance compared to swimming cells, or cells which are immobile, although the 
mechanism remains unclear (Butler, et al., 2009). The RND efflux pumps are notoriously 
involved in antibiotic resistance, and therefore, we sought to examine the role of efflux 
pump knock-outs on swarming motility grown with or without erythromycin, a potent 
biofilm inducer in some of our strains.  
 Curiously, the patterns of swarming were similar to the patterns seen with biofilm 
formation. Wild-type PA01 demonstrated limited swarming in the presence or absence of 
erthromycin (Figure 14). Whereas our pump knock-out strains, PA050 (lacking OprM, 
MexAB-OprM, MexXY, MexCD-OprJ with mini-Tn7-lac), PA0702 (lacking OprM, 
MexAB-OprM, MexXY, MexCD-OprJ) and PA01172 (lacking MexAB-OprM, MexCD-
OprJ, MexJK, MexEF-OprN, MexXY, OpmH, and TriABC) demonstrated organized 
motility in the characteristic fractal pattern associated with swarming in the presence of 
erythromycin (Figure 14). In the absence of erythromycin, limited swarming was 
observed, particularly in strains PA0702 and PA01172. Erythromycin caused an 
enhancement of biofilm production as seen in Figure 11, as a result of this; we decided to 
further investigate virulence by examining motility in the presence of erythromycin. 
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 Taken together, this data implicates erythromycin as an effector of community 
behaviour, given that it enhanced biofilm and swarming which are both considered 
organized community behaviours. Alternatively, erythromycin had no effect on 
swimming, an activity which is not organized community behaviour. Curiously, only 
strains lacking a sub-set of RND efflux pumps appear to be affected by erythromycin, as 
wild type PA01 demonstrated decreased biofilm production (Figure 11), and no real 
change in swarming activity when treated with erythromycin. It is therefore tempting to 
speculate that the loss of various RND-efflux components results in an increased stress 
response which facilitates organized community behaviours.   
D. Expression Profile of Chimeras 
 The vast majority of RND efflux pumps have broad ranges of substrates they 
recognize and are able to efflux from the cell. The outer membrane proteins of these 
pumps generate a channel through the outer membrane which allows substrate to pass 
through it, and must therefore be capable of accommodating a variety of substrates. 
Unlike the majority of RND outer membrane proteins, OprM and OpmH have a very 
narrow range of substrates when in complex with MexJK. Both of these proteins are 
capable of forming the outer membrane channel for the MexJK efflux pump and share 
approximately 60% sequence similarity, however, they efflux different substrates. These 
characteristics of close relative homology, yet unique substrate specificity provide an 
opportunity to examine the particular regions within the outer membrane proteins which 
are responsible for substrate specificity. We decided to modify OprM by swapping 
various OpmH domains into OprM in an attempt to modify substrate specificity. These 
chimeric proteins were confirmed by nucleotide sequencing (Figure 16). The helix 1 and 
helix 3 regions of OprM were substituted with OpmH regions, because these are the 
regions thought to interact with the RND transporter protein, and have been shown to be 
important in MexAB-OprM substrate efflux (Nehme and Poole, 2007). 
 Hypothetical homology models were modeled using OprM (which has been 
crystalized) (Figure 17a) as a template for OpmH (which is yet to be crystalized) (Figure 
17b). The regions of OprM and OpmH which may be swapped are highlighted (Figure 17 
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a and b respectively) and hypothetical homology models of each of the chimeric OprM 
proteins were generated with highlighted swapped regions (Figures 17d-g).  
 Despite relatively high sequence similarities between OprM and OpmH at the 
amino acid level (~60%); the two proteins have different substrate profiles. MexJK-
OprM is capable of tetracycline and erythromycin efflux, whereas MexJK-OpmH is 
capable of triclosan efflux. This provided a unique opportunity to examine which regions 
within the proteins are critical to substrate efflux. Resistance to triclosan was not 
conferred to OprM in chimeras where helix 1, or helix 1 and 3, or helix 1 to 3 were 
swapped (Table 6). However, we found that when only helix 3 of OprM was replaced 
with OpmH there was an increase in resistance to triclosan (Table 6). This is a very 
interesting result because we have identified a region in OpmH (amino acids 425-440 
located in helix 3) which confers the ability to efflux triclosan if inserted into OprM. 
Curiously, the ability to efflux triclosan comes at a cost; mainly the MexJK-
chimericOprM lost the ability to efflux erythromycin, an effect which was observed in all 
chimeric OprM proteins. Erythromycin and triclosan are very different molecules 
chemically. Erythromycin is a relatively large (733 Da), relatively polar molecule, 
whereas triclosan is a relatively small (289 Da), relatively hydrophobic molecule. The 
differences between these two molecules may necessitate unique outer membrane 
proteins for their efflux; however, further studies are required to confirm this observation.  
 Protein analysis demonstrated the presence of a band at approximately 50 kDa for 
strains in PA058, PA072 and PA074 but not in PA071 and PA073 (Figure 19a). When 
probed with rabbit α-OprM antibodies, OprM expression was verified in PA058, PA072, 
and PA074 (Figure 19b). Others have shown that threonine 209 is critical to protein 
translation (Nehme and Poole, 2005) and here we show that amino acids 192-206 may 
also be critical for appropriate OprM translation (Figure 18b, 19). This could indicate that 
helix 1 contains residues necessary for OprM protein translation or folding. However, 
without performing site-directed mutagenesis studies it is difficult to pinpoint the exact 
amino acid residue(s) required for appropriate translation. Curiously, double chimeras 




Figure 20. Summary of Domain Swaps made in P. aeruginosa OprM. A 
representative diagram highlighting the domains that were swapped from OpmH into 
OprM. Replaced sections of OprM with OpmH are represented by a change in colour; 
pink represents helix 1, blue represents helix 3 and yellow represents the swap 









E.  Concluding Remarks 
 The MexJK-OprM/OpmH RND efflux pump is an important component in the 
repertoire of antimicrobial resistance mechanisms at the disposal of P. aeruginosa. The 
pump is capable of tetracycline and erythromycin efflux when in complex with OprM, 
and triclosan efflux when in complex with OpmH. This is the narrowest substrate 
specificity of any of the known P. aeruginosa RND efflux pumps, making it ideal for 
molecular characterization of substrate interaction. Initially, we designed single copy 
systems to study MexJK in the presence of either OprM, or OpmH. We confirmed these 
constructs using qRT, immunoblot, and MIC phenotype. Next, we examined the role of 
the MexJK-OprM/OpmH efflux pump on P. aeruginosa virulence by assessing biofilm 
formation, quorum sensing, and motility. We found that erythromycin plays an important 
role in organized community behaviour, enhancing biofilm formation, and swarming. 
Finally, we determine regions within the OprM/OpmH proteins which are critical to 
substrate specificity. We substituted 15 amino acids from OpmH into OprM generating a 
chimeric OprM protein which gained the ability to efflux triclosan. Together this data 

















 While domains in OprM were replaced from those in OpmH, those in OpmH were 
not replaced by OprM. It would be interesting to see if helix three of OprM also modifies 
resistance in the same pattern as that from OpmH did. In order to do this, the same 
procedure would be adapted only this time taking regions from OprM and inserting them 
into OpmH. Next, phenotypic analysis in the form of MIC's would need to be performed 
to check the phenotype to see if the chimeric OpmH strains had gained the ability to 
efflux erythromycin; it would be interesting to see if the loss of native substrate 
specificity was also seen in these chimeras. We would also run SDS-PAGE and 
immunoblotting to ensure protein was being produced. Protein was not produced in all of 
the OprM chimeras, since the swaps would be taking place in the same regions of the 
protein, it would be interesting to see if the same possible destabilization effect and 
possible rescue was seen when both domains were swapped at the same time as was seem 
in the OprM chimeras (Figure 19b). 
 A region potentially responsible for substrate specificity was identified in OpmH 
and a very broad region in OprM was shown to effect erythromycin efflux and protein 
production. In order to narrow down the range of amino acids, site-directed mutagenesis 
studies on specific amino acids from helix three in OpmH should be performed to 
identify specific amino acids that facilitate the efflux of triclosan by the MexJK pump. As 
well, upon completion of the domain swapping experiments in OpmH, these same site-
directed mutagenesis experiments should be carried out in OprM. 
 The mechanism of interaction between the MexJK-OprM/OpmH complex is 
currently unknown. Pull-down assays to investigate the interaction between the RND 
transporter protein and the OMP should be performed. Since both outer membranes have 
been his tagged, it would be fairly uncomplicated to check for an interaction with MexK 
in a nickel-NTA column, as described in the materials and methods. Additionally, if 
OprM and MexK are pulled down in the presence and absence of substrate, it should be 
obvious whether or not the complex is substrate dependent or constitutively expressed. If 
bands appear for MexK only when substrate is present it would indicate that the complex 
is substrate dependent, if bands for MexK appear in both variables, then it indicates the 
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APPENDIX A. Lactobacillus rhamnosus R011 cell free supernatant sensitizes P. 
aeruginosa strains to various antibiotics in MIC checkerboard assay.(a) Summary table 
(b) -(l) Raw data from MIC plates, each set of two represents one 96-well plate. The top 
table contains the antibiotic concentrations used, while the bottom plate contains the 
amount of cell free supernatant added. Yellow colour represents a change in MIC and red 
colour represents the final MIC. Cell free supernatant from Lactobacillus rhamnosus 
R011 was grown overnight in deMan, Rogosa and Sharpe (MRS) medium, cells were 
removed by centrifugation and subsequent 0.22 µm filtration. 96-well plates were 












Change Cell Free 
Supernatant 
Added (µl) 
PA01 Ciprofloxacin 0.6 0.3 2 6.25 
PA01172 Ciprofloxacin 0.15 0.0000732 2049 0.09766 





PA01172 Trimethoprim 4 0.0039063 1024 0.09766 




PA01172 Chloramphenicol 4 0.025 160 0.78125 




PA01172 Carbenicillin 64 0.125 512 0.0488 













0.00000 1.20000 0.60000 0.30000 0.15000 0.07500 0.03750 0.01875 0.00938 0.00469 0.00234 0.00117 
 0.30000 0.15000 0.07500 0.03750 0.01875 0.00938 0.00469 0.00234 0.00117 0.00059 0.00029 
 0.07500 0.03750 0.01875 0.00938 0.00469 0.00234 0.00117 0.00059 0.00029 0.00015 0.00007 
 0.01875 0.00938 0.00469 0.00234 0.00117 0.00059 0.00029 0.00015 0.00007 0.00004 0.00002 
 0.00469 0.00234 0.00117 0.00059 0.00029 0.00015 0.00007 0.00004 0.00002 0.00001 0.00000 
 0.00117 0.00059 0.00029 0.00015 0.00007 0.00004 0.00002 0.00001 0.00000 0.00000 0.00000 
 0.00029 0.00015 0.00007 0.00004 0.00002 0.00001 0.00000 0.00000 0.00000 0.00000 0.00000 
 0.00007 0.00004 0.00002 0.00001 0.00000 0.00000 0.00000 0.00000 0.00000 0.00000 0.00000 
 
Lactobacillus cell free supernatant µl 
0.00000                  
25.0000
0 
6.25000 1.56250 0.39063 0.09766 0.02441 0.00610 0.00153 0.00038 0.00010 0.00002 0.00001 
12.5000
0 
3.12500 0.78125 0.19531 0.04883 0.01221 0.00305 0.00076 0.00019 0.00005 0.00001 0.00000 
6.25000 1.56250 0.39063 0.09766 0.02441 0.00610 0.00153 0.00038 0.00010 0.00002 0.00001 0.00000 
3.12500 0.78125 0.19531 0.04883 0.01221 0.00305 0.00076 0.00019 0.00005 0.00001 0.00000 0.00000 
1.56250 0.39063 0.09766 0.02441 0.00610 0.00153 0.00038 0.00010 0.00002 0.00001 0.00000 0.00000 
0.78125 0.19531 0.04883 0.01221 0.00305 0.00076 0.00019 0.00005 0.00001 0.00000 0.00000 0.00000 







0.000 1.2000 0.6000 0.3000 0.1500 0.0750 0.0375 0.0188 0.0094 0.0047 0.0023 0.0012 
 0.3000 0.1500 0.0750 0.0375 0.0188 0.0094 0.0047 0.0023 0.0012 0.0006 0.0003 
 0.0750 0.0375 0.0188 0.0094 0.0048 0.0023 0.0012 0.0006 0.0003 0.0002 0.0001 
 0.0187 0.0093 0.0047 0.0023 0.0013 0.0006 0.0003 0.0002 0.0001 0.0001 0.0001 
 0.0046 0.0023 0.0012 0.0006 0.0003 0.0002 0.0001 0.0001 0.0000 0.0000 0.0000 
 0.0012 0.0006 0.0002 0.0002 0.0001 0.0001 0.0000 0.0000 0.0000 0.0000 0.0000 
 0.0003 0.0002 0.0002 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000 
 0.0001 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000 
 
Lactobacillus cell free supernatant µl 
0.00000            
25.0000 6.250000 1.562500 0.390625 0.097656 0.024414 0.006104 0.001526 0.000382 0.000095 0.000024 0.000006 
12.5000 3.125000 0.781250 0.195313 0.048828 0.012207 0.003052 0.000763 0.000191 0.000048 0.000012 0.000003 
6.25000 1.562500 0.390625 0.097656 0.024414 0.006104 0.001526 0.000382 0.000095 0.000024 0.000006 0.000002 
3.12500 0.781250 0.195313 0.048828 0.012207 0.003052 0.000763 0.000191 0.000048 0.000012 0.000003 0.000001 
1.56250 0.390625 0.097656 0.024414 0.006104 0.001526 0.000381 0.000095 0.000024 0.000006 0.000002 0.000000 
0.78125 0.195313 0.048828 0.012207 0.003052 0.000763 0.000191 0.000048 0.000012 0.000003 0.000001 0.000000 







0.00000 256.000 128.000 64.0000 32.0000 16.0000 8.00000 4.00000 2.00000 1.00000 0.50000 0.25000 
 64.0000 32.0000 16.0000 8.00000 4.00000 2.00000 1.00000 0.50000 0.25000 0.12500 0.06250 
 16.0000 8.00000 4.00000 2.00000 1.00000 0.50000 0.25000 0.12500 0.06250 0.03125 0.01563 
 4.00000 2.00000 1.00000 0.50000 0.25000 0.12500 0.06250 0.03125 0.01563 0.00781 0.00391 
 1.00000 0.50000 0.25000 0.12500 0.06250 0.03125 0.01563 0.00781 0.00391 0.00195 0.00098 
 0.25000 0.12500 0.06250 0.03125 0.01563 0.00781 0.00391 0.00195 0.00098 0.00049 0.00024 
 0.06250 0.03125 0.01563 0.00781 0.00391 0.00195 0.00098 0.00049 0.00024 0.00012 0.00006 
 0.01563 0.00781 0.00391 0.00195 0.00098 0.00049 0.00024 0.00012 0.00006 0.00003 0.00002 
 
Lactobacillus cell free supernatant µl 
0.00000                    
25.0000 6.25000 1.56250 0.39063 0.09766 0.02441 0.00610 0.00153 0.00038 0.00010 0.00002 0.00001 
12.5000 3.12500 0.78125 0.19531 0.04883 0.01221 0.00305 0.00076 0.00019 0.00005 0.00001 0.00000 
6.25000 1.56250 0.39063 0.09766 0.02441 0.00610 0.00153 0.00038 0.00010 0.00002 0.00001 0.00000 
3.12500 0.78125 0.19531 0.04883 0.01221 0.00305 0.00076 0.00019 0.00005 0.00001 0.00000 0.00000 
1.56250 0.39063 0.09766 0.02441 0.00610 0.00153 0.00038 0.00010 0.00002 0.00001 0.00000 0.00000 
0.78125 0.19531 0.04883 0.01221 0.00305 0.00076 0.00019 0.00005 0.00001 0.00000 0.00000 0.00000 







0.00000 64.0000 32.0000 16.0000 8.00000 4.00000 2.00000 1.00000 0.50000 0.25000 0.12500 0.06250 
 16.0000 8.00000 4.00000 2.00000 1.00000 0.50000 0.25000 0.12500 0.06250 0.03125 0.01563 
 4.00000 2.00000 1.00000 0.50000 0.25000 0.12500 0.06250 0.03125 0.01563 0.00781 0.00391 
 1.00000 0.50000 0.25000 0.12500 0.06250 0.03125 0.01563 0.00781 0.00391 0.00195 0.00098 
 0.25000 0.12500 0.06250 0.03125 0.01563 0.00781 0.00391 0.00195 0.00098 0.00049 0.00024 
 0.06250 0.03125 0.01563 0.00781 0.00391 0.00195 0.00098 0.00049 0.00024 0.00012 0.00006 
 0.01563 0.00781 0.00391 0.00195 0.00098 0.00049 0.00024 0.00012 0.00006 0.00003 0.00002 
 0.00391 0.00195 0.00098 0.00049 0.00024 0.00012 0.00006 0.00003 0.00002 0.00001 0.00000 
 
Lactobacillus cell free supernatant µl 
0.00000                    
25.0000 6.25000 1.56250 0.39063 0.09766 0.02441 0.00610 0.00153 0.00038 0.00010 0.00002 0.00001 
12.5000 3.12500 0.78125 0.19531 0.04883 0.01221 0.00305 0.00076 0.00019 0.00005 0.00001 0.00000 
6.25000 1.56250 0.39063 0.09766 0.02441 0.00610 0.00153 0.00038 0.00010 0.00002 0.00001 0.00000 
3.12500 0.78125 0.19531 0.04883 0.01221 0.00305 0.00076 0.00019 0.00005 0.00001 0.00000 0.00000 
1.56250 0.39063 0.09766 0.02441 0.00610 0.00153 0.00038 0.00010 0.00002 0.00001 0.00000 0.00000 
0.78125 0.19531 0.04883 0.01221 0.00305 0.00076 0.00019 0.00005 0.00001 0.00000 0.00000 0.00000 
















8.00000 4.00000 2.00000 1.00000 0.50000 0.25000 0.12500 
 32.0000 16.0000 8.00000 4.00000 2.00000 1.00000 0.50000 0.25000 0.12500 0.06250 0.03125 
 8.00000 4.00000 2.00000 1.00000 0.50000 0.25000 0.12500 0.06250 0.03125 0.01563 0.00781 
 2.00000 1.00000 0.50000 0.25000 0.12500 0.06250 0.03125 0.01563 0.00781 0.00391 0.00195 
 0.50000 0.25000 0.12500 0.06250 0.03125 0.01563 0.00781 0.00391 0.00195 0.00098 0.00049 
 0.12500 0.06250 0.03125 0.01563 0.00781 0.00391 0.00195 0.00098 0.00049 0.00024 0.00012 
 0.03125 0.01563 0.00781 0.00391 0.00195 0.00098 0.00049 0.00024 0.00012 0.00006 0.00003 
 0.00781 0.00391 0.00195 0.00098 0.00049 0.00024 0.00012 0.00006 0.00003 0.00002 0.00001 
 
Lactobacillus cell free supernatant µl 
0.00000                    
25.0000 6.25000 1.56250 0.39063 0.09766 0.02441 0.00610 0.00153 0.00038 0.00010 0.00002 0.00001 
12.5000 3.12500 0.78125 0.19531 0.04883 0.01221 0.00305 0.00076 0.00019 0.00005 0.00001 0.00000 
6.25000 1.56250 0.39063 0.09766 0.02441 0.00610 0.00153 0.00038 0.00010 0.00002 0.00001 0.00000 
3.12500 0.78125 0.19531 0.04883 0.01221 0.00305 0.00076 0.00019 0.00005 0.00001 0.00000 0.00000 
1.56250 0.39063 0.09766 0.02441 0.00610 0.00153 0.00038 0.00010 0.00002 0.00001 0.00000 0.00000 
0.78125 0.19531 0.04883 0.01221 0.00305 0.00076 0.00019 0.00005 0.00001 0.00000 0.00000 0.00000 







0.00000 16.0000 8.00000 4.00000 2.00000 1.00000 0.50000 0.25000 0.12500 0.06250 0.03125 0.01563 
 4.00000 2.00000 1.00000 0.50000 0.25000 0.12500 0.06250 0.03125 0.01563 0.00781 0.00391 
 1.00000 0.50000 0.25000 0.12500 0.06250 0.03125 0.01563 0.00781 0.00391 0.00195 0.00098 
 0.25000 0.12500 0.06250 0.03125 0.01563 0.00781 0.00391 0.00195 0.00098 0.00049 0.00024 
 0.06250 0.03125 0.01563 0.00781 0.00391 0.00195 0.00098 0.00049 0.00024 0.00012 0.00006 
 0.01563 0.00781 0.00391 0.00195 0.00098 0.00049 0.00024 0.00012 0.00006 0.00003 0.00002 
 0.00391 0.00195 0.00098 0.00049 0.00024 0.00012 0.00006 0.00003 0.00002 0.00001 0.00000 
 0.00098 0.00049 0.00024 0.00012 0.00006 0.00003 0.00002 0.00001 0.00000 0.00000 0.00000 
 
Lactobacillus cell free supernatant µl 
0.00000                    
25.0000 6.25000 1.56250 0.39063 0.09766 0.02441 0.00610 0.00153 0.00038 0.00010 0.00002 0.00001 
12.5000 3.12500 0.78125 0.19531 0.04883 0.01221 0.00305 0.00076 0.00019 0.00005 0.00001 0.00000 
6.25000 1.56250 0.39063 0.09766 0.02441 0.00610 0.00153 0.00038 0.00010 0.00002 0.00001 0.00000 
3.12500 0.78125 0.19531 0.04883 0.01221 0.00305 0.00076 0.00019 0.00005 0.00001 0.00000 0.00000 
1.56250 0.39063 0.09766 0.02441 0.00610 0.00153 0.00038 0.00010 0.00002 0.00001 0.00000 0.00000 
0.78125 0.19531 0.04883 0.01221 0.00305 0.00076 0.00019 0.00005 0.00001 0.00000 0.00000 0.00000 










64.0000 32.0000 16.0000 8.00000 4.00000 2.00000 1.00000 0.50000 0.25000 0.12500 0.06250 
 16.0000 8.00000 4.00000 2.00000 1.00000 0.50000 0.25000 0.12500 0.06250 0.03125 0.01563 
 4.00000 2.00000 1.00000 0.50000 0.25000 0.12500 0.06250 0.03125 0.01563 0.00781 0.00391 
 1.00000 0.50000 0.25000 0.12500 0.06250 0.03125 0.01563 0.00781 0.00391 0.00195 0.00098 
 0.25000 0.12500 0.06250 0.03125 0.01563 0.00781 0.00391 0.00195 0.00098 0.00049 0.00024 
 0.06250 0.03125 0.01563 0.00781 0.00391 0.00195 0.00098 0.00049 0.00024 0.00012 0.00006 
 0.01563 0.00781 0.00391 0.00195 0.00098 0.00049 0.00024 0.00012 0.00006 0.00003 0.00002 
 0.00391 0.00195 0.00098 0.00049 0.00024 0.00012 0.00006 0.00003 0.00002 0.00001 0.00000 
 
Lactobacillus cell free supernatant µl 
0.000                    
25.00 6.25000 1.56250 0.39063 0.09766 0.02441 0.00610 0.00153 0.00038 0.00010 0.00002 0.00001 
12.50 3.12500 0.78125 0.19531 0.04883 0.01221 0.00305 0.00076 0.00019 0.00005 0.00001 0.00000 
6.250 1.56250 0.39063 0.09766 0.02441 0.00610 0.00153 0.00038 0.00010 0.00002 0.00001 0.00000 
3.125 0.78125 0.19531 0.04883 0.01221 0.00305 0.00076 0.00019 0.00005 0.00001 0.00000 0.00000 
1.562 0.39063 0.09766 0.02441 0.00610 0.00153 0.00038 0.00010 0.00002 0.00001 0.00000 0.00000 
0.781 0.19531 0.04883 0.01221 0.00305 0.00076 0.00019 0.00005 0.00001 0.00000 0.00000 0.00000 







0.00000 128.00000 64.00000 32.00000 16.00000 8.00000 4.00000 2.00000 1.00000 0.50000 
  32.00000 16.00000 8.00000 4.00000 2.00000 1.00000 0.50000 0.25000 0.12500 
  8.00000 4.00000 2.00000 1.00000 0.50000 0.25000 0.12500 0.06250 0.03125 
  2.00000 1.00000 0.50000 0.25000 0.12500 0.06250 0.03125 0.01563 0.00781 
  0.50000 0.25000 0.12500 0.06250 0.03125 0.01563 0.00781 0.00391 0.00195 
  0.12500 0.06250 0.03125 0.01563 0.00781 0.00391 0.00195 0.00098 0.00049 
  0.03125 0.01563 0.00781 0.00391 0.00195 0.00098 0.00049 0.00024 0.00012 
  0.00781 0.00391 0.00195 0.00098 0.00049 0.00024 0.00012 0.00006 0.00003 
 
Lactobacillus cell free supernatant µl 
0.00000               
25.0000 6.25000 1.56250 0.39063 0.09766 0.02441 0.00610 0.00153 0.00038 0.00010 0.00002 0.00001 
12.5000 3.12500 0.78125 0.19531 0.04883 0.01221 0.00305 0.00076 0.00019 0.00005 0.00001 0.00000 
6.25000 1.56250 0.39063 0.09766 0.02441 0.00610 0.00153 0.00038 0.00010 0.00002 0.00001 0.00000 
3.12500 0.78125 0.19531 0.04883 0.01221 0.00305 0.00076 0.00019 0.00005 0.00001 0.00000 0.00000 
1.56250 0.39063 0.09766 0.02441 0.00610 0.00153 0.00038 0.00010 0.00002 0.00001 0.00000 0.00000 
0.78125 0.19531 0.04883 0.01221 0.00305 0.00076 0.00019 0.00005 0.00001 0.00000 0.00000 0.00000 











8.00000 4.00000 2.00000 1.00000 0.50000 0.25000 0.12500 0.06250 0.03125 
 8.00000 4.00000 2.00000 1.00000 0.50000 0.25000 0.12500 0.06250 0.03125 0.01563 0.00781 
 2.00000 1.00000 0.50000 0.25000 0.12500 0.06250 0.03125 0.01563 0.00781 0.00391 0.00195 
 0.50000 0.25000 0.12500 0.06250 0.03125 0.01563 0.00781 0.00391 0.00195 0.00098 0.00049 
 0.12500 0.06250 0.03125 0.01563 0.00781 0.00391 0.00195 0.00098 0.00049 0.00024 0.00012 
 0.03125 0.01563 0.00781 0.00391 0.00195 0.00098 0.00049 0.00024 0.00012 0.00006 0.00003 
 0.00781 0.00391 0.00195 0.00098 0.00049 0.00024 0.00012 0.00006 0.00003 0.00002 0.00001 
 0.00195 0.00098 0.00049 0.00024 0.00012 0.00006 0.00003 0.00002 0.00001 0.00000 0.00000 
 
Lactobacillus cell free supernatant µl 
0.00000                    
25.0000 6.25000 1.56250 0.39063 0.09766 0.02441 0.00610 0.00153 0.00038 0.00010 0.00002 0.00001 
12.5000 3.12500 0.78125 0.19531 0.04883 0.01221 0.00305 0.00076 0.00019 0.00005 0.00001 0.00000 
6.25000 1.56250 0.39063 0.09766 0.02441 0.00610 0.00153 0.00038 0.00010 0.00002 0.00001 0.00000 
3.12500 0.78125 0.19531 0.04883 0.01221 0.00305 0.00076 0.00019 0.00005 0.00001 0.00000 0.00000 
1.56250 0.39063 0.09766 0.02441 0.00610 0.00153 0.00038 0.00010 0.00002 0.00001 0.00000 0.00000 
0.78125 0.19531 0.04883 0.01221 0.00305 0.00076 0.00019 0.00005 0.00001 0.00000 0.00000 0.00000 







0.00000 8.00000 4.00000 2.00000 1.00000 0.50000 0.25000 0.12500 0.06250 0.03125 0.01563 0.00781 
 2.00000 1.00000 0.50000 0.25000 0.12500 0.06250 0.03125 0.01563 0.00781 0.00391 0.00195 
 0.50000 0.25000 0.12500 0.06250 0.03125 0.01563 0.00781 0.00391 0.00195 0.00098 0.00049 
 0.12500 0.06250 0.03125 0.01563 0.00781 0.00391 0.00195 0.00098 0.00049 0.00024 0.00012 
 0.03125 0.01563 0.00781 0.00391 0.00195 0.00098 0.00049 0.00024 0.00012 0.00006 0.00003 
 0.00781 0.00391 0.00195 0.00098 0.00049 0.00024 0.00012 0.00006 0.00003 0.00002 0.00001 
 0.00195 0.00098 0.00049 0.00024 0.00012 0.00006 0.00003 0.00002 0.00001 0.00000 0.00000 
 0.00049 0.00024 0.00012 0.00006 0.00003 0.00002 0.00001 0.00000 0.00000 0.00000 0.00000 
 
Lactobacillus cell free supernatant µl 
0.00000                    
25.00000 6.25000 1.56250 0.39063 0.09766 0.02441 0.00610 0.00153 0.00038 0.00010 0.00002 0.00001 
12.50000 3.12500 0.78125 0.19531 0.04883 0.01221 0.00305 0.00076 0.00019 0.00005 0.00001 0.00000 
6.25000 1.56250 0.39063 0.09766 0.02441 0.00610 0.00153 0.00038 0.00010 0.00002 0.00001 0.00000 
3.12500 0.78125 0.19531 0.04883 0.01221 0.00305 0.00076 0.00019 0.00005 0.00001 0.00000 0.00000 
1.56250 0.39063 0.09766 0.02441 0.00610 0.00153 0.00038 0.00010 0.00002 0.00001 0.00000 0.00000 
0.78125 0.19531 0.04883 0.01221 0.00305 0.00076 0.00019 0.00005 0.00001 0.00000 0.00000 0.00000 
0.39063 0.09766 0.02441 0.00610 0.00153 0.00038 0.00010 0.00002 0.00001 0.00000 0.00000 0.00000 
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APPENDIX B. The effect of cell free supernatant from Lactobacillus rhamnosus has on P. aeruginosa biofilm formation. 






APPENDIX C . The effect of cell free supernatant from Acinetobacter baumanii and E. 
coli strains on the production of biofilm in P. aeruginosa. Biofilm formation was 
measured with the addition of cell free supernatant from ATCC 19606, AB030, AB031 



























APPENDIX D. Letter of permission from the Journal of Bacteriology to reprint Figure 










APPENDIX E. Pull-down assay using Ni-NTA resin column chromatography and silver 
staining protocol. 
Pull-Down Assay Using Ni-NTA Resin Column Chromatography 
 Pull down assays were performed using methods described by Pierce 
Biotechnologies, 2008 (Pierce Biotechnologies, 2008) and Cuenca et al. (Cuenca, et al., 
2003). Overnight cultures were subcultured 1:100 v/v into 1 L LB and grown to an 
A600nm= 1.0, appropriate antibiotic and 1 mM IPTG was added at an A600nm= 0.6 when 
required. Cultures were centrifuged at 4740 x g for 10 minutes at 4 °C and the resulting 
pellet was frozen overnight at -20 °C. Pellets were thawed and re-suspended in 100 mL 
cross-linking buffer (150 mM NaCl, 20 mM sodium phosphate, pH 7.2) followed by the 
addition of Dithiobis [succinimidylpropionate] (DSP) (0.2 mM). The solution was 
incubated for 30 mins at 37 °C before being quenched with 125 mL Tris-HCl (pH 7.5). 
Cells were harvested by centrifugation at 4740 x g for 10 mins at 4 °C, re-suspended in 
150 mL 1 M Tris-HCl (pH 7.4), lysed by French Press (2000 psi) and ultra-centrifuged at 
105000 x g for 1 hr at 4 °C. The ultra-centrifuge pellet was resuspended in 2 x 2 mL (4 
mL total) solubilisation buffer (20 mM sodium phosphate, 0.5 M NaCl, 8 M Urea, 10 
mM Imidazole, 0.1% w/v SDS, pH 7.4), and this material was designated "column 
starting material". Ni-NTA columns were prepared using 3 mL Ni-NTA resin (Fisher, 
Rockford, IL, USA), according to the manufacturers instruction, in brief, resin was 
degassed under vacuum in equilibration buffer (20 mM sodium phosphate, 300 mM 
NaCl, 10 mM Imidazole, 8 M Urea, pH7.4) and poured using a glass rod to limit gas 
within the matrix. The columns were equilibrated with no less than 10 column volumes 
of equilibration buffer. Column starting material was applied to the column and incubated 
for 1 hr at room temperature. Unbound protein was eluted with 2 column volumes 
equilibration buffer, and designated as column flow through. Loosely bound proteins 
were eluted with 10 mL of wash buffer (0.5 M NaCl, 20 mM Tris, 10 mM Imidazole, 
0.1% w/v SDS, 8 M Urea, pH 8.0) and designated wash flow through. Bound protein was 
eluted with elution buffer (50 mM Tris, 8 M Urea, 2% w/v SDS, 0.4 M Imidazole, pH 
6.8), in 0.5 mL fractions (10), and assessed for purity using SDS-PAGE with silver 
staining, or immunoblotting. Any protein still bound to the column was removed with 10 
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column volumes of MES buffer (20 mM 2-[N-morpholine]-ethanesulfonic acid, 0.1 M 
NaCl, pH 5.0), followed by 10 column volumes of distilled water. Columns were stored 
in two column volumes of column storage solution (20% (v/v) ethanol in distilled water). 
Columns were regenerated before use with 10 column volumes of MES buffer, followed 
by 10 column volumes distilled water, and were re-equilibrated as described above. 
Silver Staining 
 Silver staining was performed on polyacrylamide gels according to Merril et al. 
(Merril, et al., 1981). Briefly, 200 mL of prefix solution (50% v/v methanol, 10% v/v 
ethanol, and 40% v/v distilled water) was added to the gel and heated in a microwave 
oven (Danby designer model) for 1.5 minutes at 50% power. The gel was removed from 
the microwave and shaken for approximately 10 seconds every 30 seconds. The gel was 
then incubated in the prefix solution for 2 mins at room temperature with shaking. Prefix 
solution was decanted and replaced with 200 mL of distilled water and microwaved for 2 
minutes at 50% power. The gel was removed from the microwave and shaken for 10 secs 
every 30 secs. The gel was then incubated in distilled water for 2 ms at room temperature 
with shaking. Water was decanted and replaced with a 100 µM dithiothreitol (DTT) 
solution and heated in the microwave oven as above for 2 minutes. The gel was then 
incubated in the DTT solution for 2 mins at room temperature with shaking. DTT 
solution was decanted and replaced with a silver nitrate solution (0.1% w/v in 200 mL 
distilled water) and heated in a microwave oven for 1.5 minutes as described above. The 
silver nitrate was decanted, the gel was washed twice with 200 mL of distilled water and 
replaced with 200 mL of sodium carbonate (3% w/v sodium carbonate, 0.019% v/v 
formaldehyde) and incubated at room temperature with shaking until the protein bands 
reached desired intensity. Developer solution was decanted and replaced with 10 mL of 
2.3 M citric acid solution for 1 minute with shaking to halt the reaction. Citric acid 
solution was decanted and the gel was washed with 200 mL of distilled water. The gel 





APPENDIX F. Pull down assay of induced OpmH in the presence and absence of 
triclosan. (a) Silver stain of SDS-PAGE with the following samples: 1. Ladder. 2. 
triclosan sample. 3. No triclosan sample. 4. pET1.6-OpmH with 1.0mM IPTG. 5. pET1.6 
without 1.0mM IPTG. 6. Starting material with triclosan. 7. Starting material without 
triclosan. 8. Supernatant with triclosan. 9. Supernatant without triclosan. (b) Immunoblot 
were probed with a 1:10000 dilution of polyclonal Goat α-OpmH antibody, and 
subsequently probed with a 1:20000 dilution of (HRP)-conjugated mouse α-goat 
antibody. 1. Triclosan sample. 2. No triclosan sample. 3. pET1.6-OpmH with 1.0mM 
IPTG. 4. Starting material with triclosan. 5. Starting material without triclosan. 6. 
Supernatant with triclosan. 7. Supernatant without triclosan. 8. Pellet with triclosan. 9. 
















OprM, Helix 1 
Single 2 2 
PA072 MexJ, MexK, 
OprM, Helix 3 
Single 2 8 
PA073 MexJ, MexK, 
OprM, Helix 1 to 
Helix 3 
Single 2 2 
PA074 MexJ, MexK, 
OprM, Helix 1 
and Helix 3 
Single 2 2 
PA050 MexJ. MexK None 2 2 
PA051 MexJ,MexK, 
OpmH 
Single 2 64 
PA058 MexJ, MexK, 
OprM 
Single 2 2 
 
